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ABSTRACT 
Nanocrystalline silver (NCS) dressings have antimicrobial and anti-inflammatory effects 
which aid healing, particularly in burns and chronic wounds. However, they are cytotoxic and 
may delay healing in acute wounds. Therefore, this study aimed to assess the effect of a NCS 
dressing on wound healing in full-thickness excisional wounds in a porcine model. 
 
Healing of porcine skin was assessed on day 3, 6, 9 and 15 post-wounding. Five wounds 
dressed with NCS and five untreated wounds dressed with polyurethane film (the control) 
were assessed per day (n=40 wounds). The rate of healing was measured using digital 
photographs. The inflammatory response, restoration of the epithelium and blood vessel 
formation were evaluated using haematoxylin and eosin stained sections. Picrosirius red 
staining and confocal microscopy were used to assess collagen formation. Proliferation of 
keratinocytes was calculated using sections immunolabelled for Ki-67. Additionally, the 
quality of the re-epithelialised wounds was assessed using a Clinical Assessment Score.  
 
There was no difference in the rate of healing between wounds treated with NCS and those 
dressed with polyurethane film. Inflammation was increased in NCS-treated wounds on day 3 
post-wounding. However, compared to controls, on day 15 post-wounding the epithelium of 
NCS-treated wounds more closely resembled normal epithelium. Additionally, a greater 
number of mature blood vessels were seen in NCS-treated wounds. Differences were also 
observed in the deposition of collagen in NCS-treated wounds compared to controls.  
 
These results suggest that NCS may be beneficial for scar formation. Further investigation is 
needed into the effect of NCS and its role in the treatment of wounds, including novel uses 
such as the prevention of scarring.  
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1. INTRODUCTION AND LITERATURE REVIEW 
Adult cutaneous wound healing is a complex sequence of molecular and cellular events, 
which culminates in the replacement of damaged tissue by a scar (Ho and Hantash, 2013). 
Therapeutic agents used to treat wounds aim to increase the rate of healing and maximize the 
production of functional scar tissue (Ho and Hantash, 2013). This aim is achieved by 
optimizing the molecular and cellular events of cutaneous healing and controlling local 
factors, such as infection, which can prolong inflammation and delay wound healing (Guo 
and DiPietro, 2010; Ho and Hantash, 2013). One such therapeutic agent, Acticoat
TM
 which 
contains nanocrystalline silver, has reported antimicrobial and anti-inflammatory properties 
(Atiyeh et al., 2007; Khundkar et al., 2010) which may aid wound healing. However, silver 
nanoparticles are cytotoxic to a number of cell types, including keratinocytes and fibroblasts 
(for examples see Asharani et al., 2009; Samberg et al., 2010). Additionally, there are 
conflicting reports on the ability of these dressings to improve the rate of wound healing (for 
examples see Olson et al., 2000; Innes et al., 2001). Therefore, further investigation is needed 
to determine the effect of nanocrystalline silver on cutaneous wound healing.  
 
1.1 Normal cutaneous wound healing 
In humans, cutaneous wound healing occurs primarily through the process of re-
epithelialisation (Sullivan et al., 2001) with varying degrees of wound contraction.  These 
events form part of the complex process of healing which can be divided into three phases. 
After skin injury, the initial or inflammatory phase of healing is characterized by haemostasis 
and the recruitment of inflammatory cells to the wound area (Ho and Hantash, 2013). These 
events merge with the second or proliferative phase of healing. During this phase damaged 
tissue is replaced with new epithelium (re-epithelialisation), blood vessels (neoangiogenesis) 
and extracellular matrix (ECM) components (Ho and Hantash, 2013). Through these 
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processes as well as wound contraction, in which the wound periphery advances towards the 
centre of the wound (Ehrlich and Hunt, 2012), the wound is closed. Finally, in the remodeling 
phase, the new ECM within the healed wound is transformed to create a mature, acellular 
scar (Ho and Hantash, 2013).   
 
Therapeutic agents, such as nanocrystalline silver, impact on the complex cellular and 
molecular events of each of the above phases. Therefore, an understanding of these events is 
vital to appreciate the effects of the therapeutic agent on healing.  
 
1.1.1 Early wound healing: the inflammatory phase  
At the time of a cutaneous injury, endothelial damage and exposure of blood constituents to 
ECM proteins, such as collagen, initiate platelet aggregation and the coagulation cascade 
(Reinke and Sorg, 2012).  Besides achieving haemostasis, the resulting fibrin clot provides a 
temporary ECM into which the cells involved in cutaneous wound healing can migrate. 
Furthermore, tissue damage and platelet aggregation cause the release of multiple cytokines 
which initiate the inflammatory response and mediate the proliferative phase of healing (Ho 
and Hantash, 2013).  
 
Neutrophils are the first inflammatory cells in the wound and are recruited to the wound 
immediately after haemostasis is achieved (Broughton et al., 2006; Wilgus et al., 2013). They 
produce a number of antimicrobial substances and proteases. These include reactive oxygen 
species (ROS) and matrix metalloproteinases (MMPs), which aid the phagocytosis of 
microbes and damaged tissue (Broughton et al., 2006; Wilgus et al., 2013). Additionally, 
neutrophils increase the inflammatory response by releasing pro-inflammatory cytokines 
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which recruit other inflammatory cells, such as macrophages, to the wound (Reinke and Sorg, 
2012; Wilgust al., 2013).  
 
Approximately 72 hours after skin injury, macrophages replace neutrophils in the wound 
(Reinke and Sorg, 2012). Initially, macrophages perform an antimicrobial function, secrete 
pro-inflammatory cytokines which regulate the inflammatory response and produce MMPs 
and other proteases, which break down damaged tissue before it is removed by phagocytosis 
(Broughton et al., 2006; Sindrilaru and Scharffetter-Kochanek, 2013). As inflammation 
resolves, macrophages undergo a phenotypic change and become a primary source of 
cytokines and growth factors (Broughton et al., 2006; Sindrilaru and Scharffetter-Kochanek, 
2013). These factors initiate the proliferative phase of cutaneous wound healing by 
stimulating keratinocyte, fibroblast and endothelial cell migration and proliferation (Baum 
and Arpey, 2005; Broughton et al., 2006).  
 
1.1.2 Intermediate wound healing: the proliferative phase 
The proliferative phase of cutaneous wound healing begins approximately three days after 
injury (Reinke and Sorg, 2012). It is mediated by macrophages, keratinocytes and fibroblasts 
through cell-ECM interactions and the release of cytokines and growth factors (Baum and 
Arpey, 2005; Broughton et al., 2006; Werner et al., 2007), a few of which are discussed 
below. During the proliferative phase, the inflammatory response decreases and keratinocyte, 
fibroblast and endothelial cell migration and proliferation increase (Ho and Hantash, 2013). 
 
Re-epithelialisation is the process by which keratinocytes migrate, proliferate and terminally 
differentiate to cover the wound with a keratinized, stratified squamous epidermis (Li et al., 
2007). After injury, interleukin (IL)-1, IL-6, IL-8, tumour necrosis factor (TNF)- α, platelet 
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derived growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor 
(TGF)-β and keratinocyte growth factor (KGF; also known as fibroblast growth factor 7) as 
well as keratinocyte-ECM interactions induce basal and suprabasal keratinocytes adjacent to 
the wound edge to change into a migratory phenotype (Sivamani et al., 2007; Werner et al., 
2007). These cells are able to detach from the basement membrane and adjacent cells and 
migrate into the wound along the temporary ECM components (Sivamani et al., 2007). A 
vital characteristic of migrating keratinocytes is the ability to secrete MMPs. MMP-2 and 
MMP-9 are particularly important for digestion of ECM components allowing keratinocytes 
to move through the fibrin clot (Ågren, 1999; Sivamani et al., 2007).  
 
As keratinocytes migrate into the wound and form tongues of new epithelium, keratinocyte 
proliferation is stimulated by IL-1, IL-6, IL-8, TNF-α, PDGF, EGF and KGF (Sivamani et 
al., 2007; Werner et al., 2007). Initially, epithelial stem cells, found in the basal layer of the 
uninjured epidermis as well as epidermal appendages adjacent to the wound edge, proliferate 
(Sivamani et al., 2007; Reinke and Sorg, 2012). This provides a supply of keratinocytes 
which can migrate into the wound (Braiman-Wilksman et al., 2007). As re-epithelialisation 
progresses, keratinocyte proliferation also occurs within the new epithelium (Braiman-
Wilksman et al., 2007).  
 
In the final process of re-epithelialisation the keratinocytes terminally differentiate to form a 
keratinized, stratified squamous epithelium (Li et al., 2007). Terminal differentiation, 
stimulated by TGF-β (Werner and Smola, 2001), begins in the new epithelium at the wound 
edge and progresses along the new epithelium towards the centre of the wound (Braiman-
Wilksman et al., 2007). However, it does not occur at the centre of the wound until epidermal 
continuity is restored (Odland and Ross, 1968; Braiman-Wilksman et al., 2007). 
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Oxygen and nutrients are vital for the function of fibroblasts, keratinocytes and the 
inflammatory cells within the cutaneous wound. Hypoxia and the acidic milieu created by 
anaerobic metabolism are potent stimuli for angiogenesis (Baum and Arpey, 2005). After 
skin injury, vascular endothelial growth factor (VEGF) and other angiogenic factors are 
released by macrophages, keratinocytes, fibroblasts and endothelial cells (Ho and Hantash, 
2013). In response to VEGF, pericytes and endothelial cells from blood vessels adjacent to 
the wound loosen their cell junctions and detach from the basement membrane (Carmeliet 
and Jain, 2011). Endothelial cells secrete MMPs and migrate into the fibrin clot under the 
influence of VEGF, TGF-β, fibroblast growth factor (FGF) and the components of the ECM 
to which the cells are now exposed (Javerzat et al., 2002; Pardali et al., 2010; Carmeliet and 
Jain, 2011; Greaves et al., 2013). The leading or tip cell determines the direction of migration 
in response to angiogenic factors while the stalk cells behind it proliferate and form a lumen 
(Carmeliet and Jain, 2011). Initially, the endothelial tubes are leaky and blood flows poorly 
through them (Carmeliet and Jain, 2011; DiPietro, 2013). Pericytes, stimulated by TGF-β, 
PDGF and angiopoetins, surround the endothelial tubes (Carmeliet and Jain, 2011). A new 
basement membrane is deposited and endothelial cell junctions are increased. This stabilises 
the vessels improving blood flow (Carmeliet and Jain, 2011). Endothelial tubes which have 
poor blood flow regress whereas those that have good blood flow and are surrounded by 
pericytes persist (Carmeliet and Jain, 2011). Thus a mature, functional vascular network is 
formed within the new ECM.  
 
Restoration of damaged ECM begins during the proliferative phase and continues into the 
remodelling phase of cutaneous healing (Ho and Hantash, 2013). Under the influence of 
PDGF, TGF-β, IL-1, TNF-α FGF, EGF, interferon (IFN)-γ and ECM components such as 
cysteine rich 61 (cyr61), fibroblasts from the adjacent non-wounded dermis migrate into the 
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wound area, proliferate and secrete the components of a permanent ECM (Baum and Arpey, 
2005; Broughton et al., 2006). Starting three to five days after injury, fibroblasts secrete 
collagens, proteoglycans and glycosaminoglycans, replacing the fibrin clot with a 
collagenous matrix (Baum and Arpey, 2005). TGF-β and fibroblast-ECM interactions are of 
particular importance as they control not only collagen synthesis, but also the secretion of 
MMPs by fibroblasts and differentiation of fibroblasts into myofibroblasts (Baum and Arpey, 
2005; Broughton et al., 2006). Myofibroblasts can be found in the wound from day four or 
six after injury and are important in wound contraction, decreasing the size of the skin wound 
(Baum and Arpey, 2005). As with keratinocytes, MMPs play an important role in the 
migration of fibroblasts into the wound area. In addition, they are vital for the remodelling of 
the ECM from the temporary matrix of the fibrin clot into the collagenous matrix of a mature, 
functional scar (Baum and Arpey, 2005). Therefore, the secretion of MMPs and their 
inhibitors, tissue inhibitors of matrix metalloproteinases (TIMPs), are carefully regulated by 
TGF-β, IL1, cyr61, PDGF and EGF (Baum and Arpey, 2005).  
 
1.1.3 Late wound healing: the remodeling phase 
The collagen secretion that began three to five days after injury, in the proliferative phase of 
healing, continues at an increased rate for approximately three weeks (Baum and Arpey, 
2005). Fibroblast-ECM interactions as well as TNF-α and IL-1 then mediate a decrease in 
collagen synthesis until the rate of collagen synthesis by fibroblasts and degradation by 
MMPs are equal. In this steady state remodelling occurs and may continue for 12 months 
(Baum and Arpey, 2005).  
 
During the proliferative phase, fibroblasts lay down type III collagen and proteoglycans. In 
the remodelling phase, these ECM components are replaced by type I collagen which is 
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secreted by fibroblasts along lines of tension in the wound (Baum and Arpey, 2005; 
Broughton et al., 2006). As remodelling progresses, the collagen fibres within the wound are 
aligned parallel to the wound surface (Ehrlich and Krummel, 1996). In addition, increased 
fibril cross-linking results in stronger collagen fibres with larger diameters (Baum and Arpey, 
2005). Larger collagen fibres aid wound contraction and increase the tensile strength of the 
wound (Baum and Arpey, 2005; Ehrlich and Hunt, 2012). Wound contraction, mediated by 
myofibroblasts, occurs for approximately 14 days after skin injury and further decreases the 
size of the wound area. Concurrently, the number of blood vessels within the wound 
decreases and fibroblasts undergo apoptosis (Baum and Arpey, 2005). Thus, remodelling 
increases the tensile strength of the scar and results in the morphological characteristics of an 
acellular, ‘mature’ scar (Baum and Arpey, 2005).  
 
This simplistic description of events in cutaneous wound healing belies the true complexity 
of the process. Growth factors may influence healing in different types of wounds in 
distinctive ways. Over-expression of TGF-β in partial-thickness wounds results in increased 
re-epithelialisation whereas in full-thickness wounds it delays healing (Tredget et al., 2005). 
In addition, the equilibrium of different growth factors and cytokines within a wound, the 
time at which they are expressed and ECM interactions all influence the effect of a particular 
factor (Sivamani et al., 2007; Wilgus 2012; Greaves et al., 2013). Furthermore, cleavage of 
factors by MMPs can result in factor activation or inactivation (Ho and Hantash, 2013; 
McCarty and Percival, 2013) or the formation of alternative isoforms with different functions 
(Carmeliet and Jain, 2011). Thus, the correct balance of growth factors, cytokines, MMPs and 
TIMPs are vital for the progression of healing. Indeed, an increased inflammatory response, 
excessive MMP activity and abnormalities in cytokine and growth factor expression are the 
hallmarks of chronic wounds (Widgerow, 2012).   
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1.2 Silver in wound healing 
Traditionally, ionic silver (Ag
+
), in the form of silver salts or silver sulfadiazine, has been 
used to treat wounds that are infected or at risk of infection (Khundkar et al., 2010). The 
rationale for using these dressings is the antimicrobial action of Ag
+ 
against gram negative 
and gram positive bacteria, including resistant strains, as well as fungal pathogens (Atiyeh et 
al., 2007).  This broad spectrum of antimicrobial activity, which is concentration dependent, 
is attributed to the ability of Ag
+ 
to affect the bacterial cell wall, disrupt the respiratory chain 
and inhibit protein, RNA and DNA synthesis (Percival et al., 2005). While bacterial 
resistance to silver has been described, it is transient and infrequent (Percival et al., 2005). 
Therefore, silver is an attractive topical therapeutic and prophylactic antimicrobial agent, 
particularly in light of the emergence of multi-drug resistant bacteria (Khundkar et al., 2010).  
 
However, there is evidence that Ag
+
 is toxic to keratinocytes and fibroblasts in vitro 
(McCauley et al., 1989; Hidalgo and Domínguez, 1998; Lee and Moon, 2003; Fraser et al., 
2004; Poon and Burd, 2004) and that wounds treated with Ag
+
 heal more slowly compared to 
other dressings (Malik et al., 2010; Dokter et al., 2013; Hoeksema et al., 2013; Wasiak et al., 
2013; Vloemans et al., 2014).  An additional concern when using Ag
+
 dressings is the 
increased pain and treatment cost due to frequent dressing changes (Tredget et al., 1998; 
Varas et al., 2005; Muangman et al., 2006; Cox et al., 2011). Ag
+
 is delivered to the wound 
in a bolus form and is rapidly inactivated by chloride, proteins and other compounds within 
the wound (Atiyeh et al., 2007).  Therefore, frequent dressing changes are needed to maintain 
the concentration of Ag
+
 and thereby its antimicrobial effects (Atiyeh et al., 2007).  
 
Technological advances have allowed the formulation of dressings which release Ag
+
 into the 
wound in a sustained manner. Acticoat
TM
, one of the slow-release silver dressings, consists of 
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two layers of polyethylene mesh coated with silver nanoparticles (<20nm diameter) 
surrounding a layer of absorbent rayon polyester gauze (Dunn and Edward-Jones, 2004; 
Atiyeh et al., 2007).  As the silver is impregnated in the mesh, it is continuously released into 
the wound providing a sustained silver concentration over the time the dressing is used. 
Additionally, both ionic (Ag
+
) and non -ionic (Ag
0
) silver are released by Acticoat
TM 
(Atiyeh 
et al., 2007). Ag
0
 is deactivated less rapidly than Ag
+
 by chloride, proteins and other 
compounds in the wound (Atiyeh et al., 2007). Furthermore, Ag
0
 is ionized within the wound 
environment to provide an additional source of Ag
+
, the active form of silver (Atiyeh et al., 
2007). Thus, nanocrystalline silver dressings lead to a sustained concentration of active silver 
within the wound. This negates the need for frequent dressing changes thus improving 
patients perception of pain and decreasing treatment costs (Tredget et al., 1998; Varas et al., 
2005; Muangman et al., 2006; Atiyeh et al., 2007; Cox et al., 2011).   
 
Wounds treated with silver nanoparticles may heal faster that those treated with other forms 
of silver (Cuttle et al., 2007; Huang et al., 2007; Tian et al., 2007; Nadworny et al., 2008; 
Gravante and Montone, 2010; Wasiak et al., 2013). In addition, Acticoat
TM
 is a more 
effective antimicrobial agent than silver sulfadiazine (Wright et al., 1999; Yin et al., 1999; 
Uygur et al., 2009) as well as a number of other silver containing dressings (Thomas and 
McCubbin, 2003; Fong et al., 2005; Heggers et al., 2005; Edwards-Jones, 2006; Ip et al., 
2006; Castellano et al., 2007). These differences are attributed to the sustained silver 
concentration released by Acticoat
TM
 (Thomas and McCubbin, 2003; Castellano et al., 2007), 
as well as the unique properties of the nanoparticles (Aityeh et al., 2007; Foldbjerg et al., 
2009; Park et al., 2011; Beer et al., 2012). Therefore, the present review is restricted to in 
vivo or in vitro studies which investigate the effects of silver nanoparticles.   
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Due to their small size, silver nanoparticles are able to enter cells by endocytosis (AshaRani 
et al., 2009; Wei et al., 2010; Greulich et al., 20011b; Haase et al., 2011; Singh and Ramarao, 
2012). Within the cytoplasm, the silver nanoparticles are found near or in the nucleus and 
mitochondria (AshaRani et al., 2009; Wei et al., 2010; Greulich et al., 2011b; Haase et al., 
2011; Hackenberg et al., 2011; Singh and Ramarao, 2012; Bressan et al., 2013; Rigo et al., 
2013). Silver nanoparticles affect mitochondrial structure and function which induces 
oxidative stress with the generation of ROS and decreases cell viability (Carlson et al., 2008; 
AshaRani et al., 2009; Teodoro et al., 2011; Singh and Ramarao, 2012; Bressan et al., 2013). 
While it is unclear if the generation of ROS and decreased cell viability always results in 
apoptosis and cell death (Arora et al., 2008; Hsin et al., 2008; Van den Plas et al., 2008; 
AshaRani et al., 2009; Foldbjerg et al., 2009; Singh and Ramarao, 2012; Rigo et al., 2013), it 
is clear that ROS damage DNA (Ahamed et al., 2008; Arora et al., 2008; AshaRani et al., 
2009; Kalishwaralal et al., 2009; Hackenberg et al., 2011). This inhibits cell proliferation and 
causes arrest in the G2/M or S phase of the cell cycle (AshaRani et al., 2009; Park et al., 
2010; Wei et al., 2010; Zanette et al., 2011; Beer et al., 2012).   
 
The above effects are dependent on the length of exposure to and concentration of the silver 
nanoparticles (Arora et al., 2008; AshaRani et al., 2009; Greulich et al., 2009; Park et al., 
2010; Wei et al., 2010; Greulich et al., 2011a; Greulich et al., 2011b; Hackenberg et al., 
2011). Furthermore, smaller silver nanoparticles (Carlson et al., 2008; Wei et al., 2010; Park 
et al., 2011) and those that are not coated by stabilising agents, display increased toxicity 
(Samberg et al., 2010; de Lima et al., 2012). Culture of keratinocytes with unwashed- or 
washed- uncoated silver nanoparticles (20nm, 50nm and 80nm) at concentrations of 
0.34µg/ml to 1.7µg/ml decreased cell viability compared to untreated controls and carbon 
coated silver nanoparticles (25nm and 35nm) (Samberg et al., 2010).   
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Additionally, silver nanoparticles have different effects on different cell types. Fibroblasts are 
more susceptible to the toxic effects of silver nanoparticles than keratinocytes (Van Den Plas 
et al., 2008; Liu et al., 2010) or macrophages (Park et al., 2011) and monocytes and T-cells 
respond differently to silver nanoparticles (Greulich et al., 2011a). Polyvinylpyrrolidone-
coated (PVP) silver nanoparticles decreased cell viability when cultured with HaCaT cells 
(<48.8nm, >6.25µg/ml) (Zanette et al., 2011), endothelial cells (<5nm, >20µg/ml) (Kang et 
al., 2011), monocytes (<90nm, >25µg/ml) (Greulich et al., 2011a) and human mesenchymal 
stem cells (100nm, >3.5µg/ml) (Greulich et al., 2009). Furthermore, decreased cell viability 
is seen in human fibroblasts cultured with silver nanoparticles (5-15nm) at concentrations 
greater than 100µM
# 
(Liu et al., 2010) in endothelial cells cultured with silver nanoparticles 
(50nm) at concentrations greater than 500nM (Gurunathan et al., 2009; Kalishwaralal et al., 
2009) and in mouse macrophages cultured with silver nanoparticles (<90nm) at 
concentrations of 0.8 and 1.6ppm^ (Park et al., 2010).  
 
Release of silver from Acticoat
TM
 creates a sustained silver concentration of silver between 
70µg/g and 100µg/g in human serum substitute* (Rigo et al., 2012). This concentration is 
substantially higher than those at which silver nanoparticles decrease cell viability in vitro 
(for examples see Arora et al., 2008; Carlson et al., 2008; Liu et al., 2010; Samberg et al., 
2010; Park et al., 2011).  Indeed, decreased viability is reported in keratinocytes, HaCaT cells 
and fibroblasts cultured with Acticoat
TM
 (Fraser et al., 2004; Lam et al., 2004; Poon and 
Burd, 2004; Burd et al., 2007; Van Den Plas et al., 2008; Kempf et al., 2011). This is one 
reason Acticoat
TM
 is not recommended for the treatment of acute, non-inflamed wounds 
(Widgerow, 2010). 
 
# 1µM is approximately equal to 0.1µg/ml  ^ 1ppm is approximately equal to 1µg/ml 
* 1µg/g in human serum substitute is approximately equal to 1µg/ml 
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However, in vitro results may not be directly transferable to the clinical situation. Studies on 
wound fluid have shown that the quantity and type of proteins present in chronic wounds 
differ from acute wounds (Widgerow, 2011). As the silver released from Acticoat
TM
 forms 
complexes with chloride and proteins (Rigo et al., 2012), the wound environment may affect 
the concentration of silver within the wound. In addition, the complexity of the cell 
environment influences the activity of silver nanoparticles. Fewer keratinocytes and 
fibroblasts are viable when cultured with silver nanoparticles delivered in water or saline 
compared to culture media containing growth factors (Burd et al., 2007).  
 
Furthermore, silver nanoparticles affect cell function as well as viability. Toxic 
concentrations of silver nanoparticles inhibit endothelial cell migration and tube formation 
(Gurunathan et al., 2009; Kalishwaralal et al., 2009) and human mesenchymal stem cell 
migration in vitro (Greulich et al., 2009). Additionally, toxic concentrations of silver 
nanoparticles stimulate secretion of IL-1, IL-6 and TNF-α by macrophages (Carlson et al., 
2008; Park et al., 2010; Singh and Ramarao, 2012) and keratinocytes (Samberg et al., 2010) 
and decrease the secretion of IL-6, Il-8 and VEGF by human mesenchymal stem cells in vitro 
(Greulich et al., 2009; Hackenberg et al., 2011). However, lower non-toxic concentrations of 
silver nanoparticles can increase or decrease the function of different cell types.  
 
Fibroblasts cultured with more than 25µM silver nanoparticles (5-15nm) produce less 
collagen and hydroxyproline and undergo a phenotypic change to myofibroblasts (Liu et al., 
2010). The phenotypic change was confirmed in vivo in a mouse model of full-thickness 
excisional wounds treated with a dressing containing 0.04mg/cm
2
 of silver nanoparticles, 
which showed increased α-SMA expression on day 7 post-wounding (Liu et al., 2010).  
 
 
  1µM is approximately equal to 0.1µg/ml   1ppm is approximately equal to 1µg/ml 
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Increased endothelial cell migration and tube formation, mediated via VEGF receptor 
signaling pathways, was reported when endothelial cells were cultured with PVP-coated 
silver nanoparticles (<5nm, concentration 5µg/ml to 20µg/ml) (Kang et al., 2011). These 
changes were associated with increased VEGF expression in endothelial cells (Kang et al., 
2011). Similarly, increased VEGF expression has been described in mesenchymal stem cells 
cultured with non-toxic concentrations of silver nanoparticles (<80nm, ≤1µg/ml) 
(Hackenberg et al., 2011). Additionally, in a mouse matrigel model, thicker and more 
functional blood vessels were found in matrigel impregnated with 200µg (10mg/kg) of PVP 
coated silver nanoparticles (<5nm) than in matrigel which did not contain silver 
nanoparticles, ten days after the matrigel was injected into the mice (Kang et al., 2011).  
 
Silver nanoparticles also affect the secretion of MMPs and TIMPs. Macrophages cultured 
with 0.8ppm and 1.6ppm of silver nanoparticles (<90nm) showed decreased expression of 
MMP-3, MMP-11 and MMP-19 RNA as well as TIMP-1 RNA (Park et al., 2010). Silver 
nanoparticles are also able to directly affect the function of MMPs.  Acticoat
TM
 and solutions 
of silver extracted from Acticoat
TM
 decrease the activity of MMP -2, MMP -9 (Walker et al., 
2007) and bacterial collegenase (Shi et al., 2010; Jovanovic et al., 2012) respectively. Silver 
ions also inhibit serine proteases (Chambers et al., 1974). The decrease in MMP-2 and MMP-
9 levels and activity seen in vitro have been reproduced in vivo in porcine models of contact 
dermatitis (Nadworny et al., 2008; 2010) and contaminated wounds (Wright et al., 2002) 
treated with Acticoat
TM
. However, as MMP-2 and MMP-9 are important in re-
epithelialisation, their inhibition by Acticoat
TM
 is another reason for recommending that the 
dressing is not used for the treatment of acute, non-inflamed wounds (Widgerow, 2010). 
 
 1µM is approximately equal to 0.1µg/ml   1ppm is approximately equal to 1µg/ml 
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Changes in cytokine and growth factor secretion are also noted in cells cultured with silver 
nanoparticles. Macrophages cultured with non-toxic concentrations of silver nanoparticles 
secrete greater amounts of TNF-α (Carlson et al., 2008; Park et al., 2010; Park et al., 2011). 
Similarly, increased IL-1 and IL-6 secretion was observed in silver-nanoparticle treated 
macrophages (Carlson et al., 2008; Park et al., 2011) and human mesenchymal stem cells 
(Hackenberg et al., 2011). Increased IL-6 and IL-8 secretion was also noted when human 
blood monocytes were cultured with PVP coated silver nanoparticles at concentrations 
between 5µg/ml and 20µg/ml (Greulich et al., 2011a). In contrast, PVP coated silver 
nanoparticles did not affect the secretion of IL-2 or IL-4 by T-cells in vitro (Greulich et al., 
2011a).  
 
In contrast, decreased levels of TNF-α, IL-8 and TGF-β1 and increased levels of EGF, KGF, 
KGF-2 and IL-4 are described in porcine and mouse models of contact dermatitis treated with 
Acticoat
TM
 or solutions of silver nanoparticles eluted from Acticoat
TM
 compared to inactive 
controls (Nadworny et al., 2008; 2010). Similarly, in a mouse burn wound model treated with 
Acticoat
TM
 compared to silver sulphadiazine or antibiotic dressings, decreased levels of IL-6 
and increased levels of VEGF, IL-10 and IFN-γ were reported on all of the days investigated 
(Tian et al., 2007). However, TGF-β1 levels were raised within the first 5 days after injury, 
but were significantly lower beyond the 5
th
 day after injury in Acticoat
TM
-treated wounds 
(Tian et al., 2007). These changes in cytokine and growth factor expression are associated 
with a decreased inflammatory response and an increase in macrophage and 
polymorphonuclear cell apoptosis (Wright et al., 2002; Bhol and Schechter, 2004; Bhol and 
Schechter, 2005; Tian et al., 2007; Nadworny et al., 2008; Nadworny et al., 2010). Due to the 
importance of the inflammatory response in regulating cutaneous wound healing (Broughton 
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et al., 2006), the ability of silver nanoparticles to modulate cytokine and growth factor 
production and the inflammatory response is significant.  
 
Thus, silver nanoparticles may influence all phases of healing not only by direct effects on 
cell viability and function, but also through influencing cytokine, growth factor, MMP and 
TIMP expression and function. Due to these effects of silver nanoparticles as well as their 
anti-inflammatory action and potent antimicrobial activity in vitro, they are recommended for 
the treatment of wounds with high levels of inflammation, such as chronic and infected 
wounds and burns (Widgerow, 2010).  
 
Indeed, studies show improvement in chronic wounds treated with silver dressings compared 
to Allevyn (a polyurethane foam dressing) (Jørgenson et al., 2005) or local best practice 
(Münter et al., 2006). Furthermore, improved rates of healing have been found when silver 
nanoparticle solutions, creams and dressings are compared to a variety of controls in rodent 
models of excisional wounds (Liu et al., 2010; Arican et al., 2012; Prestes et al., 2012), burns 
(Tian et al., 2007) and contact dermatitis (Bhol and Schechter, 2005). Similarly, improved 
healing is seen in silver nanoparticle-treated porcine donor sites compared to petrolatum 
gauze (Olson et al., 2000), porcine models of contaminated wounds (Wright et al., 2002) and 
porcine models of contact dermatitis (Nadworny et al., 2008; 2010). In addition, clinical 
studies have shown improved re-epithelialisation of split thickness skin graft donor sites 
when treated with Acticoat
TM
 as compared to Allevyn (Argirova et al., 2007) as well as split 
thickness skin graft recipient sites when treated with Acticoat
TM
 compared to a standard 
Xeroform dressing (Demling and DeSanti, 2002).  Furthermore, a retrospective review found 
decreased healing times in full-thickness burns treated with Acticoat
TM 
(Gravante and 
Montone, 2010). 
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However, decreased re-epithelialisation was noted in Aticoat
TM
-treated split thickness skin 
graft donor sites compared to Allevyn (Innes et al., 2001) and mouse excisional wounds 
compared to Tegaderm (Burd et al., 2007). Similarly, decreased re-epithelialisation is seen in 
porcine models of deep partial-thickness burns treated with Acticoat
TM
 compared to hydrate 
gel/ gauze dressings (Wang et al., 2010). Acticoat
TM
 also inhibited re-epithelialisation of full-
thickness wounds in a skin explant model (Fredriksson et al., 2009). Silver et al (2007) found 
no difference in healing between meshed autograft sites treated with Acticoat
TM
 or 5% 
sulfamylon. Similarly, no difference was found in the rate of healing of contact dermatitis in 
mice between silver nanoparticle creams and steroids or tacrolimus (Bhol and Schechter, 
2004; 2005). Silver dressings, including Acticoat
TM
, were also no more effective than 10% 
povidone-iodine in the treatment of MRSA infected excisional wounds in diabetic rats (Lee et 
al., 2013). Furthermore, systematic reviews report similar or worse healing times in silver- 
treated wounds compared to controls (Storm-Versloot et al., 2010; Aziz et al., 2012; 
O’Meara et al., 2013). 
 
Interpretation of these contradictory results is difficult due to the multiple wound models 
used to investigate the effect of silver nanoparticles on healing. Apart from differences in 
healing between the various animal models (Ansell et al., 2012), differences exist in the 
manner in which different types of wounds heal. Partial-thickness wounds, such as burns, 
donor sites and contact dermatitis heal predominantly through re-epithelialisation, whereas in 
full-thickness wounds, such as excisional wounds, dermal constituents play an increased role 
in healing (Davidson, 1998). Furthermore, acute non-infected wounds heal differently to 
infected or chronic wounds (Davidson, 1998; Reinke and Sorg, 2013). Thus, results from 
studies investigating partial-thickness, infected or chronic wounds may not be applicable to 
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acute, full-thickness, non-infected wounds. In addition, few studies have described the effect 
of nanocrystalline silver on the acute wound bed (Atiyeh et al., 2007).  
 
Therefore, the present study aimed to investigate the effect of a nanocrystalline silver 
dressing (Acticoat
TM
) on wound healing in acute full-thickness excisional dermal wounds in a 
porcine model.  
 
The domestic pig was chosen as the model for this study due to the known histological and 
physiological similarities between porcine and human skin (Sullivan, et al., 2001). Among 
many similarities, the arrangement of the epidermis and dermis, turnover time of epidermal 
cells, epidermal proteins and lipids, biochemical structure of collagen and the arrangement of 
vascular structures within the dermis are all comparable between humans and pigs (Mowafy 
and Cassens, 1975; Meyer et al., 1981; Meyer et al., 1982; Morris and Hopewell, 1990; 
Wollina et al., 1991; Vardaxis et al., 1997; Sullivan et al., 2001). Additionally, in both 
humans and pigs, wound healing occurs primarily through re-epithelialisation as compared to 
other common animal models, such as the mouse and rat which heal mainly through wound 
contraction (Sullivan et al., 2001).  
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As the phases of healing occur in a predictable manner in an acute wound, the events of each 
stage can be used to assess the progress of wound healing. Therefore, the following aspects 
were studied: 
1. The rate of wound closure as evidenced by the percentage change in wound area 
2. A clinical assessment of wound quality in the re-epithelialised wound 
3. A histological assessment of epithelial restoration and blood vessel formation 
4. The number of inflammatory cells in the wound 
5. The number of proliferating keratinocytes and fibroblasts 
6. An assessment of the percentage area and arrangement of collagen within the wound 
7. A quantitative estimation of collagen content  
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2. MATERIALS AND METHODS 
2.1 Experimental animals 
Nine female “Large White” pigs (Sus scrofa domesticus), which weighed between 30 and 
60kg, were used for the study.  Each pig was housed in a separate pen at the Central Animal 
Services of the University of the Witwatersrand and was given free access to food and water.  
The pigs arrived in the unit at least five days before surgery, to allow them to acclimatise. 
 
Ethical clearance for the study was obtained from the Animal Ethics Screening Committee of 
the University of the Witwatersrand (AESC number 2009/2604) (Appendix A). 
 
2.2 Wound creation and specimen collection 
Intramuscular Ketamine (11mg/kg) and Midazolam (0.3mg/kg) were used to sedate each pig 
before induction of general anaesthesia with 2-5% Isoflurane administered through a mask.  
The dorsum of the pig was shaved using animal clippers, washed with sterile water and 
draped with surgical drapes. A sterilised template was used to mark four paravertebral 
wounds of 5x20mm each, on each side of the midline. The short axis of the wound lay 
parallel to the vertebral column (Fig. 2.1). Full-thickness excisional wounds were created by 
using a scalpel blade to excise the skin of each marked area down to the fascial plane. In the 
first two pigs which underwent surgery, the wounds were spaced 20mm apart. Due to 
problems with adherence of the secondary dressing, the distance between wounds was 
increased to 40mm in subsequent experiments. 
 
Wounds to the left and right of the midline were allocated as a pair for excision on either day 
3, 6, 9 or 15 post-wounding. The allocation according to the day post-wounding varied 
between the pigs so that specimens from different regions of the dorsum of the pigs (e.g. 
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towards the head or tail) were collected on each of the excision days (Fig. 2.1). Day 3, 6, 9 
and 15 post-wounding were chosen as the days for excision to allow for investigation of the 
effect of nanocrystalline silver in all of the phases of healing (Broughton et al., 2006). 
 
Acticoat
TM
 (Smith & Nephew Medical Limited) was provided by Professor Heinz Rode, 
Department of Paediatric Surgery, School of Adolescent and Child Health of the University 
of Cape Town. Opsite
TM
 (Smith & Nephew Medical Limited) was obtained from the Central 
Animal Services of the University of the Witwatersrand. Opsite
TM
, a polyurethane film 
dressing, was selected as the control dressing as it aids healing by providing a moist 
environment (Ahamed, 1982; Kaufman and Hirshowitz, 1983; Sullivan et al., 2001).  
 
Before dressing the wounds, a calibrated scale was placed alongside each wound and 
standardised digital photographs were taken at right angles to the wound.  The dorsum of the 
pig was then cleaned with sterile water. For each wound pair, the wound on the left of the 
midline was allocated to the experimental group and dressed with the experimental dressing 
(Acticoat
TM
), which was cut to the size of the wound and moistened with sterile water as per 
the manufacturer’s instructions. The wound on the right of the midline was allocated to the 
control group and dressed with the control dressing (Opsite
TM
). All wounds received a 
secondary dressing of gauze, Opsite
TM
, Elastoplast
®
 and veterinary stocking in order to 
minimise the risk of infection and to prevent the experimental and control dressings being 
displaced when the pigs rolled on the floor or scratched their backs.  The allocation to the 
experimental group (dressed with Acticoat
TM
) or control group (dressed with Opsite
TM
) and 
to a day for excision post-wounding was recorded by the researcher. 
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Figure 2.1: Position of the wounds on the dorsum of the pig and allocation to the day for 
excision post-wounding. 
= experimental wound        = control wound; *wound pair excluded from analysis 
  
Pig 
number 
Weight 
(kg) 
The day post-wounding on which the wound was excised  
1 56.5 6* 9* None 15* 3* 
2 58.1 6* 9* None 15* 3* 
3 45.5 3 6 9 15* 15* 
4 46.4 3 6 9 15 None 
5 43.4 15* 3 6 9 None 
6 40.2 15* 15* 3* 6* 9 
7 35.8 9* 15* 3 6 15* 
8 33.9 9* 15* 3 6 15* 
9 38.75 15 9 15 15 15 
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On day 3, 6, 9, 12 and 15 post-wounding, each pig was anaesthetised in the same way as on 
the day of wound creation. The dorsum of the pig was cleaned with sterile water, taking care 
not to remove adherent scabs or damage the new epithelium beneath scabs. Surgical drapes 
were placed on the dorsum of the pig. A calibrated scale was placed alongside each wound 
and digital photographs were again taken, as on the day of wound creation.  The entire 
epidermis, dermis, hypodermis and underlying fascia of the site of the allocated experimental 
and control wounds were excised, together with a uniform perimeter of normal tissue. The 
resulting excisional site was sutured and excluded from further analysis. The excised tissue 
was fixed in 10% buffered formalin for 24 hours and then processed according to the 
protocols of the School of Anatomical Sciences (see Section 2.4). The remaining wounds 
were dressed with the experimental or control dressing as allocated, and the secondary 
dressing was applied as on the day of wound creation.  If it was thought that hair would 
interfere with the adherence of the secondary dressing, the hair was shaved using animal 
clippers before the secondary dressing was applied. 
 
Due to the pigs scratching their backs, the dressings on three experimental wounds for 
excision on day 3 post-wounding, three experimental wounds for excision on day 6 post-
wounding, four experimental wounds for excision on day 9 post wounding and eleven 
experimental wounds for excision on day 15 post-wounding were displaced from the wound 
bed (Fig. 2.1). These wounds were excluded from the study and one wound pair, allocated for 
excision on the appropriate day, was added to each pig in subsequent experiments. Therefore, 
five experimental and five control wounds were analysed for each excision day (day 3, 6, 9 
and 15) post-wounding (total number of wounds = 40).  
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2.3 Macroscopic assessment  
 
2.3.1 Measurement of the change in wound area over time 
The change in wound area over time for each of the 40 wounds was calculated using digital 
photographs taken at the time of wound creation and on days 3, 6, 9, 12 and 15 respectively 
post-wounding. The number of wounds measured for the change in area over time decreased 
on each day post-wounding as wounds were excised. Therefore, twenty experimental and 
twenty control wounds were measured for the change in wound area from day 0 to day 3 
post-wounding, fifteen experimental and fifteen control wounds for the change in wound area 
from day 0 to day 6 post-wounding, ten experimental and ten control wounds for the change 
in wound area from day 0 to day 9 post-wounding and five experimental and five control 
wounds for the change in wound area from day 0 to day 12 and to day 15 post-wounding.  
 
Using ImageJ
®
 (version 1.46), a public domain, java based image analysis programme 
available at http://rsb.info.nih.gov/nih-image/, the appropriate scale was added and the area of 
each wound was calculated by tracing the perimeter of  the un-epithelialised area of each 
wound.  Adherent scab, if present, was included within the area of the wound. Each area was 
traced three times and the average area of the wound was calculated in mm
2
 for each image 
(Branski et al., 2008; Pather, 2009).  The average area of the wound was used to calculate the 
percentage change in the area of each wound from the time of wound creation to day 3, 6, 9, 
12 or 15 post-wounding. The following formula (Pather, 2009) was used: 
 
Percentage change in area = (Area of wound on day 0 - Area of wound on day x) x 100 
       Area of wound on day 0 
 
The percentage change in the area of each wound for the appropriate time period was used for 
further analysis.  
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2.3.2 Clinical assessment of wound quality 
The “Clinical Assessment Score” was developed as a tool for the clinical and histological 
assessment of healed wounds in humans (Beausang et al., 1998). It has subsequently been 
utilised for the assessment of re-epithelialised wounds in porcine models of wound healing 
(Theunissen, 2001). The Score compares the re-epithelialised wound to the surrounding 
normal skin using five parameters, each of which is allocated a numerical value (Table 2.1). 
In addition, a visual analogue scale of 0 to 10 is used to indicate an overall assessment of 
each wound.  The visual analogue score and numerical values are added together to give an 
overall score indicating the quality and clinical acceptability of each re-epithelialised wound 
(Beausang et al., 1998).  
 
The researcher and two independent observers used the photographs of the five experimental 
and five control wounds on day 12 and 15 post-wounding to determine the Score for each re-
epithelialised wound. As photographs were used to determine the Score, the fifth parameter 
(Texture) was excluded from the Score (Beausang et al., 1998).  
 
Table 2.1: Clinical Assessment Score 
Score  A: Colour B C: Contour D: Distortion E: Texture 
1 Perfect match Matte Flush with 
surrounding skin 
None Normal 
2 Slight mismatch Shiny Slightly proud/ 
indented 
Mild Just palpable 
3 Obvious mismatch  Hypertrophic Moderate Firm 
4 Gross mismatch  Keloid Severe  Hard 
 
Adapted from: Beausang et al., 1998. 
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2.4 Biochemical and histological assessment 
All of the excised tissue from the five experimental and five control wounds for each excision 
day was divided into four pieces, each approximately 5mm in length. Each piece was fixed in 
10% buffered formalin (Appendix B1) for 24 hours, dehydrated through a series of graded 
alcohols, cleared in chloroform and embedded in paraffin wax. 
 
Serial 5µm thick sections, interspersed with five 15µm thick sections (for collagen 
estimation), were cut from the paraffin embedded tissue of the central portion of each wound 
and mounted on glass slides coated with Sta-on
®
 tissue section adhesive (Leica, USA).  
Sections of 5µm thickness were selected from three spaced regions of each experimental and 
control wound for routine haematoxylin and eosin (H & E) staining (n=120 sections), 
immunocytochemical labelling with Ki-67 (n=120 sections) and staining with 0.1% 
picrosirius red (n=120 sections).  A 15µm section adjacent to each picrosirius red stained 
5µm section was allocated for the quantitative estimation of collagen content of the wound. 
In addition three spaced 5µm sections from each wound were used to determine if bacteria 
were present within the wound by use of a Gram stain (n=120 sections) (Bancroft and 
Gamble, 2002).  
 
2.4.1 Histological analysis of haematoxylin and eosin stained sections 
Following dewaxing in xylene and rehydration of the sections through a graded series of 
alcohols, routine H & E staining (Appendix B2) was carried out on the three spaced 5µm 
sections from each experimental wound (n= 5 for each day of excision) and control wound 
(n= 5 for each day of excision).  This resulted in a total of 15 sections from experimental 
wounds and 15 sections from control wounds being analysed for each day of excision post-
wounding (n=120 H&E stained sections). 
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A Zeiss Axioskop 2 microscope fitted with a Sony 3CCD camera (magnification 0.63x) was 
used to analyse each of the 120 H&E stained sections to assess the formation of blood 
vessels, the presence of inflammatory cells and the degree of wound closure and restoration 
of the epithelium, as outlined below. 
 
Note that the figures illustrating H&E stained sections were taken using an Olympus BX61VS 
microscope and XC10 Camera using Olympus Dot Slide software (Olympus Soft Image 
solutions). As all figures were adjusted to fit the page, the scale bar in each image is 
representative of the true scale. The total magnification, included in the figure legend for 
ease of use, is indicative of the magnification of the image when it was taken and not the final 
magnification of the image. For composite images the total magnification is not included.  
 
2.4.1.1 Wound closure and restoration of the epithelium 
Wound closure was assessed histologically by determining the size of the gap between the 
edges of the epithelial tongue as well as the percentage by which the wound had closed (Jia et 
al., 2011). Three spaced sections were used from the experimental and control wounds 
excised on day 9 and day 15 post-wounding (n=15 sections from experimental wounds and 
15 sections from control wounds for each day post-wounding). These measurements were not 
performed for wounds excised on day 3 or day 6 post-wounding as, in these latter wounds, 
the wound edges moved after excision thus obviating measurement of these wounds.  
 
The restoration of the epithelium was evaluated by measuring the area and length of the 
epithelial tongue and the thickness of the epithelium at the edge of the wound and the tip of 
the epithelial tongue (Jia et al., 2011). These measurements were carried out on all 120 H&E 
stained sections.   
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Using the 10x objective, digital images were taken of the epithelial tongue on the left and 
right side of each wound. In addition, for measurement of the size of the epithelial gap, 
images were taken of the area between the tips of the epithelial tongues for wounds excised 
on day 9 and day 15 post-wounding. In cases where the region of interest could not be 
photographed in a single field of view, overlapping images were taken and reconstructed into 
a single image using Gnu Image Manipulation Program (GIMP version 2.8), a free image 
manipulation programme available online at http://www.gimp.org/downloads/. The size of 
the epithelial gap, the percentage by which the wound had closed, the area and the length of 
the epithelial tongue were measured in micrometres on these images using ImageJ
®
 (version 
1.46), after the addition of the appropriate scale.  
 
The percentage by which the wound had closed was calculated using the following formula 
Percentage closure = (Width of the wound area – epithelial gap) x 100     
     Width of the wound area 
 
The width of the wound area was measured in experimental and control wounds excised on 
day 9 and day 15 post-wounding (n=60 sections) using the straight line tool in ImageJ
®
. To 
ensure that the measurement was not increased by measuring at an angle, vertical lines were 
drawn at the junction of the wounded and non-wounded dermis beneath the epithelium on the 
left and right sides of the section. The straight line distance between these reference lines was 
measured as the width of the wound area (Fig. 2.2) (Jia et al., 2011).  For each section, each 
measurement was repeated three times and the mean width of the wound area was calculated.  
Similarly, the size of the epithelial gap between the tips of the epithelial tongues on the left 
and right side of the wound was measured three times and the mean calculated for each of the 
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three spaced sections from wounds excised on day 9 and 15 post-wounding (Fig. 2.2). The 
measurement was the straight line distance, parallel to the measurement of the width of the 
wound area, between vertical lines drawn through the most distal point of the epithelial 
tongues on the left and right sides of the section.  
 
  
2
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Figure 2.2. Representative photomicrograph of wounded skin illustrating the measurement of (a) the width of the wound area and (b) the size of the epithelial 
gap. The width of the wound area was measured between vertical lines placed at the junction of the wounded and non-wounded dermis on the left and right 
sides of the wound (lines 1 and 2). The epithelial gap was measured between vertical lines through the tips of the epithelial tongues (lines 3 and 4). *indicates 
normal collagen within the non-wounded dermis on each side of the wound.  Note: Images have been merged to create a composite image. (H&E) 
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The length of the epithelial tongue along the basal layer of the epithelium from the wound 
edge to the tip of the epithelial tongue was also measured, using the freehand line tool in 
ImageJ
®
 (Fig. 2.3). The wound edge was defined as the epithelium overlying the point of 
change from mature collagen of the normal dermis to a fibrin clot or immature collagen of the 
wound area. The tip of the epithelial tongue was defined as the most distal point of confluent 
epithelial cells on the epithelial tongue. The length of the epithelial tongue was measured 
along the basal layer of the epithelium and not, as is traditional, as the straight line distance 
perpendicular to the wound edge, from the wound edge to the tip of the epithelial tongue (Jia 
et al., 2011) as this parameter was utilised as a marker of epithelial restoration and not wound 
closure. The length along the basal layer of epithelium would indicate the migration and 
proliferation of epithelial cells in all directions, whereas measurement of the straight line 
distance might not account for epithelial cells which had not migrated in a straight line from 
the wound edge.  
 
 
Figure 2.3. Representative photomicrograph of an epithelial tongue illustrating the 
measurement of the length of the epithelial tongue from the wound edge (indicated by arrow 
‘a’) to the tip of the epithelial tongue (indicated by arrow b). Note: Images have been merged 
to create a composite image. (H&E)  
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Using the freehand tracing tool in ImageJ
®
, the perimeter of the epithelial tongue, as outlined 
in Figure 2.4, was traced and the area of the epithelial tongue calculated in µm
2
. The 
presence and position of the stratum corneum on the skin sections was variable as the stratum 
corneum separated from the stratum granulosum during sectioning and staining of tissue. 
Therefore, the stratum corneum was excluded from the area of the regenerated epithelium as 
it could not be ascertained if its absence was due to technical constraints.  
 
 
 
Figure 2.4. Representative photomicrograph of an epithelial tongue illustrating the 
measurement of the epithelial area (delineated by the black line). Arrow (a) indicates the 
wound edge and arrow (b) the tip of the epithelial tongue. Note: Images have been merged to 
create a composite image. (H&E) 
 
For sections in which re-epithelialisation was complete, the area and length of the new 
epithelium, from wound edge to wound edge, was measured three times and a mean value 
calculated for each section. For sections in which re-epithelialisation was not complete, the 
area and length of the epithelial tongue on the left and right sides of the wound were 
measured three times and an average value calculated for each side of the wound. The 
average values from the left and right sides of the wound were then added to calculate a mean 
value for each section in which re-epithelialisation was not complete. The sum of the average 
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values was used to obtain the mean value for sections in which re-epithelialisation was not 
complete, as the mean value obtained from the sections in which re-epithelialisation was 
complete included both the left and right sides of the wound. 
 
Once again, three spaced sections from each wound were utilised to acquire digital images of 
the epithelium at the wound edge and the tip of the epithelial tongue. These images, obtained 
using the 40x objective, were used to measure the thickness of the epithelium on both the 
left and right sides of each section (n=120 H&E stained sections). At later stages of healing, 
where no epithelial tongue was present due to complete re-epithelialisation, non-overlapping 
images were taken of the epithelium on the right and left of the midpoint of the regenerated 
epithelium. In cases where the region of interest could not be photographed in a single field 
of view, overlapping images were taken and reconstructed into a single image using GIMP. 
 
Two precautions were taken to ensure that measurements of the thickness of the epithelium 
were not falsely increased due to the measurement being taken at an angle through the 
epidermis. Firstly, all 120 sections selected for analysis and stained with haematoxylin and 
eosin (H&E) were cut perpendicular to the epidermis as evidenced by the cells of the stratum 
basale being columnar or cuboidal in shape and containing round to oval nuclei (Therkildsen 
et al., 1998). 
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Secondly, all images were standardised before the measurements were taken. A line (R) was 
drawn parallel to the basement membrane of the wounded epithelium and the image rotated 
so that this line was in the horizontal plane with the dermis placed inferiorly. All 
measurements were taken at 90 degrees to this line. The measurements were taken from the 
basement membrane to the superficial edge of the stratum granulosum (Fig. 2.5). If the 
basement membrane was not visible, the transition point from the stratum basale to the 
dermis was used. If the superficial edge of the stratum granulosum was not visible, the deep 
edge of the stratum corneum was used. The stratum corneum was not included in the 
measurement due to its variable presence due to desquamation and technical constraints 
during processing of the sections.  
 
After the addition of the appropriate scale using ImageJ
®
 (version 1.46), the straight line tool 
was used to perform three measurements of the thickness of the epithelium on each image, 
namely: the maximum thickness of the epithelium, the minimum thickness of the epithelium 
and the thickness of the epithelium at the point midway between the maximum and minimum 
measurements (Fig. 2.5). All three measurements were repeated three times and a mean 
epithelial thickness calculated for each image. For each section, the mean epithelial thickness 
from the right and left sides of the section were averaged to calculate the mean thickness of 
the epithelium at the wound edge and the tip of the epithelial tongue respectively.   
  
34 
 
 
 
Figure 2.5. Representative photomicrograph of new epithelium at the wound edge illustrating 
the measurement of the epithelial thickness. (R) reference line,  (a) maximum thickness, (b) 
thickness at the point midway between the maximum and minimum thickness measurements, 
(c) minimum thickness. (H&E, 20X magnification) 
 
As epidermal appendages contribute to the re-epithelialisation of wounds, they may confound 
results when assessing the effect of treatment on re-epithelialisation (Broughton et al., 2006; 
Levey et al., 2007).  Therefore, the presence or absence of epidermal appendages in the non-
wounded dermis adjacent to the wound area on each side of the wound was recorded.  
Epidermal appendages were said to be present if they were visible in the field of view when 
the non-wounded dermis adjacent to the wound was viewed with the 40x objective.  
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2.4.1.2 Presence of inflammatory cells 
Using the 40x objective, four non-overlapping, digital images were taken of the wound area 
for each H&E stained section (n=120 sections). The images were taken of the wound area 
adjacent to the non-wounded dermis in a manner which ensured that the wound area filled the 
field of view. Two images were taken on each side of the wound with the second image 
approximately 1mm deep to the first image (Fig. 2.6). In ImageJ
®
 (version 1.46), the 
appropriate scale and a grid with squares of 1000 µm
2
 were added to each image. The 
inflammatory cells, identified by their nuclei, were counted in every second square of the grid 
according to the principles outlined by Weibel and Gomez (1961). The total inflammatory 
cell count for each section, obtained by adding the counts from the four images, was 
determined three times and the mean inflammatory cell count was calculated for each section. 
 
 
 
Figure 2.6. Representative photomicrograph of wounded skin illustrating the position of the 
first (a) and second (b) images used to assess the presence of inflammatory cells.  
(H&E, 5X magnification) 
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2.4.1.3 Formation of blood vessels 
The wound area, to the left and right of the midline (Fig. 2.7), of each of the three spaced 
sections from each wound was scanned, using the 40x objective, to assess the formation of 
blood vessels. In order to distinguish blood vessels from aggregates of red blood cells within 
the fibrin clot, blood vessels were defined as a lumen with a distinct surrounding of 
endothelial cells. The number of blood vessels within the wound area was scored using a 4-
point scale in which ‘0’ indicated that no blood vessels were present and ‘3’ indicated that 
many blood vessels were present. In addition, the type of blood vessels within the wound area 
were scored using a 3-point scale in which ‘0’ indicated no blood vessels, ‘1’ indicated that a 
single layer of endothelial cells surrounded the lumen of the vessel and ‘2’ indicated that a 
second layer of tissue, indicative of either pericytes or a basement membrane, was visible 
within the vessel wall. The scores for the type and number of blood vessels from the left and 
right side of each section were averaged to give a mean score for each section. 
 
 
Figure 2.7. Representative photomicrograph of wounded skin illustrating the area of the 
wound used to assess the type and number of blood vessels. (H&E, 5X magnification)       
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2.4.2 Assessment of proliferation of keratinocytes and fibroblasts  
Ki-67 is a nuclear protein associated with all stages of cell proliferation and absent during the 
resting stage of the cell cycle (Gerdes et al., 1984). It is therefore a reliable marker of cell 
proliferation, the use of which has been validated in porcine skin (Cuttle et al., 2006).   
 
The percentage proliferating cells in the epidermis and dermis of each wound was assessed 
by immunocytochemical labelling for Ki-67 of one 5µm section from each wound mounted 
on a Superfrost
®
 Plus slide (Thermo Scientific, Germany). Only one section from each 
wound was utilised as the sections mounted on glass slides using Sta-on
®
 tissue section 
adhesive could not be used due to difficulties encountered with the antigen retrieval step of 
the immunocytochemical labelling protocol which are discussed below.  
 
Prior to immunocytochemical labelling for Ki-67, the optimal protocol for 
immunocytochemical labelling for Ki-67, including the optimal concentration of polyclonal 
rabbit antibody to Ki-67 (Novocastra, United Kingdom), was determined using 5µm sections 
of human tonsil (as recommended by the manufacturer) mounted on glass slides using Sta-
on
®
 tissue section adhesive. Ethical clearance was obtained for the use of the human tonsil 
from the University of the Witwatersrand Human Research Ethics Committee (Medical) 
(M110801) (Appendix C). 
 
In all further assays, human tonsil was used as a positive control. Negative controls were 
performed for each assay by omission of the primary and secondary antibody respectively, on 
a selection of 5µm sections which lay adjacent to the experimental and control sections which 
were labelled for Ki-67. 
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During the initial assays, sections of human tonsil mounted on glass slides using Sta-On
®
 
were incubated with ethylenediaminetetraacetic acid (EDTA) at a pH of 9.0 (Appendix C1) in 
a microwave (900W) for 10 minutes to retrieve the antigen (Ki-67) from the nucleus. In these 
experiments, polyclonal rabbit antibody to Ki-67 (Novocastra, United Kingdom) was used as 
the primary antibody and goat anti-rabbit antibody (Dako, Denmark) as the secondary 
antibody. Polyclonal rabbit antibody to Ki-67 was used as previous assays using monoclonal 
mouse antibody to Ki-67 (Sigma Aldrich, South Africa), used according to the 
manufacturer’s instructions, had not produced staining of human tonsil. In the assays using 
polyclonal rabbit antibody to Ki-67, the avidin/biotin complex kit (ABC kit, Vector 
Laboratories, USA) was used to detect the secondary antibody and diaminobenzidine (DAB) 
was used as the chromagen. This protocol (Appendix C2) produced good labelling of 
proliferating cells in human tonsil (Fig. 2.8). However, when this protocol was used for 
immunocytochemical labelling of the selected sections of the skin mounted on glass slides 
using Sta-On
®
, the sections disintegrated. As the cause of disintegration of the sections was 
thought to be the high temperature and pH to which the sections were exposed during the 
antigen retrieval step, a number of antigen retrieval techniques were tried. These included 
incubation of the sections with citrate (pH 6.0 and 8.0) (Appendix C3), EDTA (pH 8.0) and 
5% Tris urea solution (pH 9.5) (Appendix C4) in both a microwave (900W and 720W for 5, 7 
and 10 minutes) and an incubator (5, 10 and 15 minutes at 60
o
C and 95
o
C). In addition, the 
above protocols were attempted using either the goat anti-rabbit antibody and ABC kit or the 
Peroxidase Detection System (Novocastra, United Kingdom). None of these protocols 
resulted in consistent immunocytochemical labelling of proliferating cells in sections of 
human tonsil or porcine skin. Neither did these protocols resolve the issue of disintegration of 
the sections mounted on glass slides using Sta-on
®
 tissue section adhesive. 
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Figure 2.8. Representative photomicrograph of human tonsil immunolabelled with Ki-67 
(initial protocol). Arrows indicate examples of nuclei positively labelled for the Ki67 antigen. 
(DIC microscopy, 25X magnification) 
 
Ultimately, additional sections of experimental and control tissue were cut and mounted on 
Superfrost
®
 Plus slides (Thermo Scientific, Germany). The increased adherence of the 
sections to the Superfrost
® 
Plus slides allowed for the optimisation of the following protocol 
for immunocytochemical labelling of sections with Ki-67 antibody. This protocol produced 
good immunolabelling for Ki-67 in human tonsil (Fig. 2.9) as well as porcine skin. However, 
as minimal tissue remained, only one section could be obtained from each experimental and 
control wound for immunocytochemical labelling with Ki-67 antibody (n=5 sections from 
experimental wounds and 5 sections from control wounds for each day post wounding). 
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Figure 2.9. Representative photomicrograph of human tonsil immunolabelled with Ki-67 
(final protocol). Arrows indicate examples of nuclei positively labelled for the Ki67 antigen. 
(DIC microscopy, 25X magnification) 
 
Sections of the experimental and control wounds as well as the positive and negative control 
sections were dewaxed in xylene and rehydrated through a series of graded alcohols before 
being washed in running tap water for five minutes.  To retrieve the antigen from within the 
cell nucleus, the sections were placed in a solution of EDTA (pH 9.0) in a microwave (900W) 
for ten minutes. After cooling for ten minutes at room temperature and being washed in 
running tap water for 5 minutes, the sections were incubated at room temperature for five 
minutes with 100 µl of peroxidase blocker, which forms part of the Peroxidase Detection 
System. The sections were washed for five minutes in two changes of a Tris Buffered Saline 
solution (TBS) (Appendix C5). Each section was then incubated at room temperature for 5 
minutes with 100 µl of the protein blocking solution provided in the Peroxidise Detection 
System. After being washed in two changes of TBS for five minutes, each section was 
incubated overnight with 100µl of polyclonal rabbit antibody to Ki-67 diluted in TBS to a 
concentration of 1: 3000. 
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The following day, the sections were washed for five minutes in two changes of TBS before 
incubation at room temperature for 30 minutes with 100 µl of the secondary antibody 
provided in the Peroxidise Detection System. The sections were washed for five minutes in 
two changes of TBS and incubated for 30 minutes with 100µl of the strepavidin-HRP 
solution provided in the Peroxidase Detection System. Again, the sections were washed for 
five minutes in two changes of TBS. One hundred µl of DAB was diluted with 2000µl of the 
solution from the kit provided for this purpose. Each section was incubated with 100µl of 
DAB for five minutes. The excess DAB was removed from each section and the sections 
washed in running tap water for 5 minutes. The sections were then air-dried horizontally 
overnight before being passed through a graded series of alcohols and cleared in xylene 
Coverslips were mounted with entellan. 
 
Using the 40x objective in conjunction with a Nomarski (differential interference contrast –
DIC) lens, cells within the epidermis which were positively labelled for the Ki-67 antigen 
were counted in the epithelial tongue and in the non-wounded epidermis. One 253.67µm x 
190.25µm field of view of the non-wounded epidermis at the wound edge was utilised for 
this count (Fig. 2.10). The proliferating cells were identified as being within the epidermis 
due to their position above the basement membrane.  As co-localisation of the Ki-67 antibody 
with keratinocyte- or melanocyte-specific antibodies was not carried out, it was not possible 
to determine if the proliferating cells within the epidermis were keratinocytes or melanocytes. 
However, as keratinocytes are more numerous than melanocytes within the epidermis and the 
proliferation of melanocytes is slower than keratinocytes (Ross and Pawlina, 2003), the 
majority of the proliferating cells within the epidermis were taken to be keratinocytes. The 
number of proliferating keratinocytes within the epidermis on the left and right of the section 
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were counted three times and the values averaged to give a mean count of the proliferating 
keratinocytes for each section.  
 
While the above protocol produced optimal labelling of human tonsil (Fig 2.9) and porcine 
skin for Ki-67 antigen, the antigen retrieval step still resulted in disruption of the dermis. 
Therefore, analysis of the number of fibroblasts positively labelled for Ki-67 antigen in the 
dermis was not investigated further.   
 
 
Figure 2.10. Representative photomicrograph of wounded skin illustrating the area in which 
proliferating keratinocytes in the non-wounded epidermis (small boxes) and epithelial tongue 
(large box) were counted.   
(Immunocytochemical labelling for Ki-67, brightfield microscopy, 5X magnification) 
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2.4.3 Assessment of collagen 
From each of the three spaced regions of each experimental wound (n=5 wounds per day 
post-wounding) and control wound (n=5 wounds per day post-wounding), a 5µm section 
which lay adjacent to a 15µm section was utilised. These 5µm sections were dewaxed in 
xylene and rehydrated through a graded series of alcohols. The sections were then stained 
with a 0.1% solution of Sirus red in saturated picric acid (Appendix D1) (n=120 picrosirius 
red stained sections). 
 
The 25x objective (glycerine/ water) of a Zeiss confocal laser scanning microscope (LSM 
710), utilising Zen 2010 software and fitted with an Axiocam MRm camera (magnification 
1.0x), was used to acquire four 566.5µm x 566.5µm images of the wound area on each of the 
picrosirius red stained sections. Two images, indicated by the boxes labelled ‘a’ in Fig 2.11, 
were taken adjacent to the non-wounded dermis on the left and right sides of the section. The 
third and fourth images, indicated by the boxes labelled ‘b’ in Fig 2.11, were at least 1mm 
deep to image ‘a’. 
 
Figure 2.11. Representative photomicrograph of wounded skin illustrating the position of the 
first (a) and second (b) images on the left and right sides of the wound area for the assessment 
of collagen. (Picrosirius red, brightfield microscopy, 5X magnification)  
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Confocal microscopy has previously been used to view collagen in tissues stained by the 
picrosirius red method, including pig skin (Dolber and Spach, 1993; Vardaxis et al., 1997). 
However, when images of non-wounded collagen were acquired using the standard excitation 
(488nm) and emission (514nm) wavelengths described by Dolber and Spach (1993), poor 
quality images were obtained. Therefore, the same area of non-wounded collagen was imaged 
using the different rhodamine and fluorescein channels provided with the LSM 710 and the 
Zen 2010 software, in order to determine which wavelengths produced the best quality 
images.  Ultimately, using excitation and emission wavelengths of 561nm and 606nm 
respectively (rhodamine channel) produced the best fluorescent images (laser: 2%, pinhole: 
36.8µm, zoom: 0.6, digital gain: 830, digital offset: 2). As areas of the field of view which are 
not in focus do not fluoresce optimally, the collagen in these areas cannot be seen clearly. 
Therefore a second channel utilising the photomultiplier tube (PMT) was added to obtain a 
brightfield microscopy image of the same area shown in the fluorescent image. The 
fluorescent and brightfield images were combined to produce a single tif image. This ensured 
that all collagen within the field of view was visible within the image (Fig. 2.12A). For each 
of the four fields of view on each section, the combined tif image was used for image 
analysis.  
 
2.4.3.1 Percentage area of collagen 
Using ImageJ
®
 (version 1.47), thirty images of non-wounded collagen, obtained using the 
above confocal settings, were colour thresholded in the hue, saturation and brightness (HSB) 
colour space by adjusting the saturation levels so that all collagen was included in the 
thresholded image (Fig. 2.12B). As the upper saturation level did not change, only the lower 
saturation level for each image was recorded and the mean value calculated. The lower 
saturation level to use in thresholding the images of the experimental and control wounds was 
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then determined as the mean value minus two standard deviations (value = 105) as this would 
include the majority of collagen in the images.  
 
 
Figure 2.12. Representative photomicrograph of non-wounded collagen before (A) and after 
(B) thresholding. (Picrosirius red, confocal microscopy, 25X magnification)  
 
After the addition of the appropriate scale and colour thresholding as described above, the 
area of the image which contained collagen, was calculated in µm
2
 for each image from the 
experimental and control wounds. The percentage of the wound area which contained 
collagen was then calculated by dividing the area which contained collagen by the total area 
of the image. For images in which the wound area did not fill the field of view, the image was 
cropped so that the area analysed was filled by the wound. For each section, the percentage of 
the wound area which contained collagen was measured three times. The percentage values 
for the images from the same section were averaged to give a mean percentage for each 
section.  
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2.4.3.2 Qualitative assessment of collagen 
The density of collagen, collagen bundle size and organisation of collagen fibres were scored 
using scales based on those described by Singer and McClain (2006). The density of collagen 
and collagen bundle size were scored using a 5- point scale in which ‘0’ indicated the least 
dense or no collagen and ‘4’ indicated the most dense or largest bundle size. The organisation 
of collagen was scored using a 4- point scale in which ‘0’ indicated no collagen, ‘1’ 
disorganised collagen in the entire image, ‘2’ areas of organised collagen in the image and ‘3’ 
organised collagen in the entire image.  
 
2.4.3.3 Quantitative estimation of collagen 
The 15µm sections, which lay adjacent to each picrosirius red stained 5µm section, were 
allocated for the quantitative estimation of the collagen content of each wound according to 
the dye-binding method described by Lopez-De Leon and Rojkind (1985) and modified by 
Castelo-Branco et al (1994).  In this method, the absorbance values of solutions of picrosirius 
red and Fast Green, obtained by elution from a stained section, are determined by 
spectrophotometry and used to calculate the collagenous and non-collagenous protein content 
of the section.  This calculation is dependent on colour equivalence values which relate the 
absorbance values of picrosirius red and Fast Green to the concentration of collagen and non-
collagenous proteins respectively.  
 
In order to determine the colour equivalence values of collagen and non-collagenous proteins 
in this study, absorbance values obtained by the dye-binding method were plotted against 
biochemical estimations of hydroxyproline and total protein in normal pig skin (James et al., 
1990). 
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Permission was obtained from the Animal Ethics Screening Committee of the University of 
the Witwatersrand to harvest normal pig skin, 20mm x 20mm in size, from the abdomen and 
dorsum of seven pigs euthanased for reasons not associated with this study. Half of the skin 
from each region was frozen at -80
o
C and used for hydroxyproline and total protein 
determination (Woessner, 1961; Bradford, 1976; Reddy and Enwemeka, 1996). The 
remaining skin was fixed in 10% buffered formalin for 24 hours, dehydrated through a series 
of graded alcohols, cleared in chloroform and embedded in paraffin wax. Six 15µm thick 
sections cut from each block of paraffin embedded tissue were processed according to the 
dye-binding method, to give absorbance values at 540nm and 620nm. 
 
Biochemical determination of the concentrations of hydroxyproline and total protein 
To determine the hydroxyproline content of the tissue, 0.02g of normal pig skin was frozen in 
liquid nitrogen, crushed with a mortar and pestle and mixed with 50µl of 0.9% normal saline. 
Freezing the tissue in liquid nitrogen before crushing the tissue was chosen as the method to 
create the solution as previous attempts at homogenising the pig skin using an ultra-turrax 
homogeniser (IKA, Germany) were unsuccessful due to the small amount of liquid.   
 
Fifty µl of 10M sodium hydroxide was added to the above solution. The resulting solution 
was vortexed before being autoclaved at 120
o
C for 20 minutes. One hundred µl of 
Chloramine T reagent (Appendix D2) was added to 100µl of the hydrolysis solution in an 
eppendorf tube and the resulting solution was incubated at room temperature for 25 minutes 
after which 500µl of freshly prepared Ehrlich’s reagent solution (Appendix D3) was added. 
After incubation for 20 minutes at 60
o
C, 150µl of the solution was transferred to a 96 well 
plate and the absorbance read at 540nm using a spectrophotometer. The hydroxyproline 
content of the tissue was then determined from a standard curve obtained by using serial 
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dilutions of 1mg hydroxyproline in 1ml of assay buffer solution (Appendix D4). This was 
repeated three times for each piece of normal pig skin (n=10). 
 
To determine the total protein content of the tissue, 0.2g of normal pig skin was homogenised 
in 5 ml of homogenising buffer (Appendix D6) using the ultra-turrax homogeniser.  The total 
protein content of the tissue was then determined using the Bradford protein assay (Bradford, 
1976).  Standard dilutions of bovine serum albumin (50µg/ml to 1000µg/ml) (Sigma-Aldrich, 
USA) were prepared. Five microlitres of each standard solution and the homogenised 
solution were transferred to wells on a 96 well plate and 250µl of Bradford reagent (Sigma-
Aldrich, USA) was added. The resulting solutions were mixed on a rotary shaker for 30 
seconds before being incubated at room temperature for 10 minutes. The absorbance of the 
solutions was read at 595nm on a Multiskan FC spectrophotometer (Thermo Fisher 
Scientific, USA). The total protein content of the tissue was calculated from the standard 
curve. The assay was repeated three times for each piece of normal pig skin (n=10). 
 
Dye-binding method for quantitative estimation of collagen 
Each 15µm section of normal skin was placed in a small, glass cell culture plate and 
incubated sequentially for five minutes with 2ml of xylene, xylene: ethanol (v:v), ethanol, 
ethanol: distilled water (v:v) and distilled water. Each section was then incubated with 2ml 
0.01% Fast Green in saturated picric acid for 15 minutes in the dark at room temperature. The 
excess fluid was withdrawn with a pipette and each section rinsed in distilled water until the 
water was colourless. Each section was then incubated with 2ml of a solution of saturated 
picric acid containing 0.1% Sirius Red and 0.04% Fast Green for 30 minutes in the dark at 
room temperature on a rotary shaker. The excess fluid was withdrawn and each section rinsed 
in distilled water until the water was colourless. One millilitre of 0.1N sodium hydroxide in 
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absolute methanol (v:v) was added to each section and the colour eluted from the section by 
gently shaking the section in the solution for a few seconds. For each section, 150µl of the 
fluid containing the eluted dye was placed into three wells of a 96 well plate and the 
absorbance of the fluid was read immediately on an Anthos 2010 spectrophotometer at 
540nm and 620nm, the maximal absorbance of Sirius Red and Fast Green respectively.  
 
Fast Green also has absorbance at 540nm which is reported in the literature to be 7.8% of the 
absorbance at 630nm (Castelo-Branco et al., 1994). To determine the percentage absorbance 
attributable to Fast Green at 540nm, the absorbances of serial dilutions of a 0.04% Fast Green 
solution were read on the Anthos 2010 spectrophotometer (Biochrom Ltd, United Kingdom) 
at 540nm and 620nm (n=10). While there was a good correlation (r=0.99) between the 
absorbance readings at 540nm and 620nm, the relationship varied according to the 
concentration of the solution (Appendix D7). Therefore, the absorbance of Fast Green at 
540nm could not be expressed as a single percentage of the absorbance of Fast Green at 
620nm.  
 
In addition, no constant relationship could be found between the hydroxyproline and total 
protein values obtained for normal pig skin using the biochemical assays and the absorbance 
values obtained by the dye-binding method (Appendix D8). Therefore, the colour 
equivalences for collagen and total protein could not be calculated and the dye-binging 
method was not applied to the 15µm sections of experimental or control wounds.  
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2.4.4 Presence of bacteria 
Due to differences in the inflammatory cell infiltrate found in experimental and control 
wounds on day 3, 9 and 15 post-wounding, three spaced 5µm sections from each of these 
wounds (n=90) were dewaxed in xylene, rehydrated through a graded series of alcohols and 
stained using the Gram method for paraffin sections (Appendix E) (Bancroft and Gamble, 
2002). The Gram stain is used to demonstrate gram positive and gram negative bacteria 
(Bancroft and Gamble, 2002). Sections of lung tissue from individuals with pneumonia, 
obtained from the School of Pathology of the University of the Witwatersrand, were utilised 
as control sections. Use of these sections was authorised by the Chair of the Human Research 
Ethics Committee (HREC) of the University of the Witwatersrand.  
 
The granulation tissue of each stained section was viewed using the 100x objective of the 
Zeiss Axioskop 2 microscope and the presence or absence of bacteria within the fibrin clot or 
granulation tissue of wounds was noted.  
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2.5 Statistical analysis 
Microsoft Excel
®
 and Statistica (version 12) were used for all statistical analyses. 
 
2.5.1 Observer errors 
For quantitative variables, the relevant measurement, as described in section 2.5.1 to 2.5.3, 
was repeated on 10% of the sample by the primary observer as well as a second observer. 
Lin’s Concordance correlation was used to calculate the intra- and inter-observer error (Lin, 
1989). A co-efficient of 0.9 or greater was accepted as evidence of an acceptably low level of 
observer error (Allan, 1982). 
 
For categorical variables, the relevant measurement, as described in section 2.5.1 to 2.5.3, 
was repeated on the entire sample by both the primary and second observer and Cohen’s 
kappa co-efficient was used to calculate the intra- and inter-observer error (Cohen, 1960). A 
co-efficient of 0.8 or greater was accepted as evidence of acceptably low levels of observer 
error for categorical variables (Blackman and Koval, 2000).  
 
The coefficients of the Lin’s concordance correlation and Cohen’s kappa test obtained in the 
current study are presented in Appendix F.  
 
2.5.2 Calculation of mean values 
As described in section 2.5.1 to 2.5.3, mean values for each quantitative variable were 
obtained for each section. The mean values for the three spaced sections from the same 
wound were averaged to calculate a mean value for each experimental wound (n= 5 per day 
post-wounding) and control wound (n= 5 per day post-wounding).  Similarly, mean scores for 
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each experimental wound and control wound were calculated for the categorical variables, 
using the mean scores from the three spaced sections from the same wound.  
 
2.5.3 Descriptive statistics 
The distribution of the data was assessed using a Shapiro-Wilks test. A p-value greater than 
0.05 indicated that the data was normally distributed. Results of the Shapiro-Wilks test are 
presented in Appendix G.  
 
Despite the majority of the data being normally distributed (Appendix G), the median and 
minimum and maximum values were chosen to describe the data due to the small sample size 
and the tendency of the median to remain unaffected by outliers (Whitley and Ball, 2002).  
 
2.5.4 Tests for statistical significance  
Due to the small sample size, the Mann-Whitney U test was used to establish if statistical 
differences were present (p< 0.05) between experimental and control wounds on day 3, 6, 9 
and 15 post-wounding, for both quantitative and categorical variables.  
 
As the presence of epidermal appendages, the age of the pig and the region in which the 
wound is positioned can affect the rate of healing, the differences between these variables on 
day 3, 6, 9 and 15 post-wounding were assessed. A Kruskall-Wallis one-way-analysis of 
variance by ranks was used to assess if a significant difference (p< 0.05) existed in the 
presence of epidermal appendages or the weight of the pigs. Contingency tables were used to 
identify differences in the region in which the wound was positioned as well as which pigs 
were utilised for each day post-wounding.  However, due to the number of categories within 
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these latter variables as well as the small sample size, neither the Fischer exact test nor 
Pearson’s Chi- squared test was suitable to determine if differences were significant.  
 
To assess the effect of weight, region, pig and treatment group on healing between days 3, 6, 
9 and 15 post-wounding a main effects analysis of variance (ANOVA) was utilised. Levene’s 
test was used to assess the assumption that the variances were homogenous. However, the 
assumptions that the residuals were normally distributed and that the variances were 
homogenous were not met, despite log transformation of the data. Therefore, this analysis 
could not be pursued.    
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3. RESULTS 
3.1 Macroscopic assessment 
Throughout the study, no pig showed signs of adverse effects due to the nanocrystalline silver 
or systemic signs attributable to wound infection.  
 
Although inspection of the experimental and control wounds on day 3 post-wounding 
revealed erythema surrounding the edges of both wound types, this was noted to be greater in 
the experimental wounds (Fig. 3.1). In addition, by day 3 post-wounding, the area of the 
experimental wounds had increased by a median value of 47%, which was significantly 
greater than the 7% median increase in the area of the control wounds (Table 3.1).   
 
On day 6 post-wounding the increase in the area of the experimental wounds from the day of 
wound creation remained significantly greater than that of the control wounds (Table 3.1). 
However, the erythema surrounding the control wounds on day 6 post-wounding appeared to 
be greater than that surrounding the experimental wounds (Fig. 3.1). In addition, greater 
volumes of exudate were noted in control wounds on day 3, day 6 and day 9 post-wounding 
(Fig. 3.1). Signs of re-epithelialisation were not visible at the wound margins in either wound 
type on day 3 or day 6 post-wounding.  
 
In both experimental and control wounds on day 9 post-wounding, areas of re-
epithelialisation were observed at the wound margins with the central portion of the wound 
being filled with granulation tissue (Fig. 3.1). However, the area of the control wounds 
decreased significantly by a median value of 63% compared to only 31.5% in the 
experimental wounds (Table 3.1; Fig. 3.1).    
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By day 12 post-wounding there was no longer a significant difference between the change in 
the area of experimental and control wounds (Table 3.1).  However, of the five experimental 
and five control wounds remaining on day 12 post-wounding, only two control wounds were 
considered to have re-epithelialised (Fig. 3.2 C & E).  These wounds were given Clinical 
Assessment Scores of 11.5 and 10.5 on day 12 post-wounding and 10.9 and 11 respectively 
on day 15 post-wounding (Fig. 3.2 D & F).  
 
On day 15 post-wounding, the only additional wound which was considered to have re-
epithelialised was one experimental wound (Fig. 3.2 B). This wound was given a Clinical 
Assessment Score of 10.6.  All wounds obtained similar scores for each of the variables as 
well as similar values for the visual analogue scales (Table 3.2). 
 
Of the three control and four experimental wounds which were considered to be incompletely 
re-epithelialised by day 15 post-wounding, two control wounds and all four experimental 
wounds were covered by adherent scabs. The remaining control wound did not have any 
clinical sign of infection and the wound area had decreased by 80% in comparison to the day 
of wound creation. In all experimental wounds, the scabs were noted to be black due to 
discolouration from the nanocrystalline silver (Fig. 3.1).  However, discolouration of the skin 
and hair seen in experimental wounds from day 6 to day 15 post-wounding (Fig. 3.1) was 
superficial and could be removed with normal saline. No grey discolouration, suggestive of 
argyria, was noted in the normal skin surrounding the wounds or in the scars of re-
epithelialised wounds. Neither were silver deposits seen in the non-wounded dermis or 
epidermis of the sections of experimental wounds assessed histologically.  
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3.2 Histological assessment  
There was no significant difference in the presence of epidermal appendages between 
experimental and control wounds on any day post-wounding (Table 3.3- 3.6). 
  
While few significant differences were found in the measured variables between 
experimental and control wounds on any day post-wounding, differences were observed 
between the granulation tissue and new epithelium of experimental and control wounds 
(Table 3.3- 3.6). By day 15 post-wounding, it was apparent that the rete ridges and thickness 
of the new epithelium of the experimental wounds more closely resembled the epithelium of 
normal skin than did that in the new epithelium of control wounds. In addition, blood vessels 
within the granulation tissue of experimental wounds appeared more mature, with an 
additional layer of tissue seen within the vessel wall more frequently, when compared to 
control wounds.  
 
3.2.1 Histological assessment of wounds on day 3 post-wounding 
On day 3 post-wounding, newly formed epithelium was seen to extend from the wound edge 
into the wound area in both experimental and control wounds (Fig. 3.3). While no significant 
differences were found between experimental and control wounds for the measures of 
epithelial restoration (Table 3.3), the higher ranges found in the experimental wounds were 
supported by observation. When compared to control wounds, the length and thickness of the 
epithelial tongue in experimental wounds was greater and more variable (Fig. 3.4). In 
addition, experimental wounds tended to have two cell layers in the tip of the epithelial 
tongue compared to the single layer of cells found in control wounds (Fig. 3.5). In contrast to 
the above findings, preliminary results for the number of proliferating keratinocytes within 
the epidermis indicated that control wounds had a significantly greater number of 
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proliferating keratinocytes than experimental wounds (Table 3.3; Fig. 3.6). Proliferating 
keratinocytes were observed within the basal layer of cells of the epithelial tongue more 
frequently in control wounds than in experimental wounds. No proliferating keratinocytes 
were visible amongst suprabasal keratinocytes.  
 
At the wound edge, all layers of the epidermis, including the stratum corneum, were present 
in both experimental and control wounds (Fig. 3.4).  However, neither differentiated layers of 
the epidermis nor basement membrane were visible at the tip of the epithelial tongue in either 
wound type (Fig. 3.5).   
 
In both experimental and control wounds, isolated fibroblasts, aggregates of red blood cells 
and numerous inflammatory cells were visible throughout the fibrin clot which was adherent 
to the wound edge within the dermis and hypodermis (Fig. 3.7). In the control wounds the 
fibrin clot appeared larger and more organized than in the experimental wounds (Fig. 3.7). 
Quantification of the number of inflammatory cells within the wound confirmed that 
significantly more inflammatory cells were present within the wound area of experimental 
wounds than in control wounds (Table 3.3). However, on sections that were gram stained, no 
bacteria were seen within the fibrin clot of experimental or control wounds (Fig. 3.8).  
 
Neither blood vessels nor collagen were visible within the wound area of either type of 
wound (Fig. 3.7; Fig. 3.9), as is reiterated in the scores of zero obtained for the size, density 
and organization of collagen bundles as well as the type and number of blood vessels  
(Table 3.3). While the percentage area of collagen on picrosirius red stained sections, is not 
significantly different between experimental and control wounds, the variability within the 
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experimental group is substantial (Table 3.3). This may be attributed to silver particles within 
the wound area of experimental wounds (Fig. 3.10). 
 
3.2.2 Histological assessment of wounds on day 6 post-wounding 
No significant differences were found between the experimental and control wounds for any 
measure used to assess epithelial restoration on day 6 post-wounding (Table 3.4). However, 
on observation, a greater number of larger developing rete ridges as well as longer and 
thicker epithelial tongues were noted in control wounds when compared to experimental 
wounds (Figs. 3.11 and 3.12).  In contrast, at the tip of the epithelial tongue three or four 
layers of cells were found more frequently in experimental wounds whereas control wounds, 
comparable to the findings on day 3 post-wounding, tended to have one or two layers of cells 
(Table 3.4; Fig. 3.13).  Similarly to day 3 post-wounding, the layers of the epidermis, 
including the stratum basale and stratum corneum, were not visible at the tip of the epithelial 
tongue in either experimental or control wounds (Fig. 3.13).   
 
As on day 3 post-wounding, proliferating keratinocytes were found more often within the 
basal layer of the epithelial tongue of control wounds than in experimental wounds. 
Additionally, proliferating keratinocytes in experimental wounds were noted to occur as 
single cells while in control wounds they were more often arranged in groups (Fig. 3.14). 
This arrangement of cells was not related to the plane of the tissue.  
 
In contrast to day 3 post-wounding, granulation tissue filled the wound area in the majority of 
experimental and control wounds on day 6 post-wounding (Fig. 3.11).  Numerous fibroblasts 
as well as variable numbers of adipocytes, inflammatory cells and blood vessels were seen 
within the granulation tissue of both experimental and control wounds on day 6 post-
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wounding (Fig. 3.15).  Scores for the number and type of blood vessels indicate that both 
experimental and control wounds contained an intermediate number of blood vessels with a 
single layer of cells in the wall of the vessel (Table 3.4; Fig. 3.15). Similar to day 3 post-
wounding, silver particles were visible within the dermis of experimental wounds on day 6 
post-wounding.  
 
On day 6 post-wounding, most experimental and control wounds contained small collagen 
bundles, arranged close to the non-wounded dermis, which were neither densely packed nor 
well organised (Table 3.4; Fig. 3.16). However the amount of collagen visible in both wound 
types was very variable with some wounds displaying large, densely packed bundles of 
collagen while others contained no collagen. In general, denser collagen and larger collagen 
bundles were observed in a greater number of control wounds as compared to experimental 
wounds. 
 
3.2.3 Histological assessment of wounds on day 9 post-wounding 
On day 9 post-wounding, both experimental and control wounds were approximately 70% 
healed (Table 3.5).  In regions of the wound which were not completely re-epithelialised, the 
layers of the epidermis, including the stratum corneum and stratum basale, were visible in the 
new epithelium a variable distance from the wound edge but not at the tip of the epithelial 
tongue. This was similar to day 6 post-wounding (Figs. 3.17 and 3.18).  In contrast, in the 
regions of the wound which were completely re-epithelialised, the distinct layers of the 
epidermis, including the stratum corneum, were noted throughout the new epithelium of both 
experimental and control wounds (Figs. 3.19 and 3.20). However, when compared to the 
epithelium of normal porcine skin, the stratum granulosum and stratum corneum of the new 
epithelium in both wound types contained a greater number of nuclei (Fig. 3.20). 
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Additionally, the thickness of the new epithelium of experimental wounds more closely 
resembled normal skin whereas that of control wounds was more variable being either thinner 
or thicker than the epithelium of normal skin (Figs. 3.19 and 3.20).  This observation was also 
noted in regions of the wound which had not completely re-epithelialised. These latter 
observations are reflected in the higher range values for the area of the new epithelium and 
length of the epithelial tongue seen in experimental wounds (Table 3.5).  However, in both 
wound types on day 9 post-wounding, the number and size of developing rete ridges as well 
as the number of cell layers at the tip of the epithelial tongue (Figs. 3.17 and 3.19) were 
highly variable.  
 
Similarly to day 6 post-wounding, proliferating keratinocytes in control wounds were 
grouped and were seen more frequently within the basal layer of the new epithelium. In the 
experimental wounds the proliferating keratinocytes were more common within the basal 
layer of the non-wounded epidermis and as single cells (Fig. 3.21).  
 
By day 9 post-wounding, granulation tissue filled the wound area of all experimental and 
control wounds (Figs. 3.22 and 3.23). The amount and density of granulation tissue was 
similar in both wound types. While numerous adipocytes and fibroblasts were visible in both 
wound types, they were less densely arranged than on day 6 post-wounding (Fig. 3.24). An 
intermediate number of blood vessels were still present in both experimental and control 
wounds. However, a second layer of tissue was visible within the vessel wall in a greater 
number of blood vessels in both wound types than on day 6 post-wounding (Table 3.5; Fig. 
3.24).  
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Inflammatory cells appeared to be more numerous in regions of both wound types which had 
not completely re-epithelialised. In experimental wounds additional aggregations of 
inflammatory cells were seen around silver deposits at the level of the lower dermis  
(Fig. 3.23). These inflammatory cells formed nodules which also contained giant cells as well 
as cells with large, pale-staining, basophilic nuclei and prominent nucleoli, and were 
suggestive of granulomas (Fig. 3.25). No bacteria were visible within the granulomas on 
gram staining of the experimental sections (Fig.3.26).  
 
On day 9 post-wounding, a great deal of variability was still seen in the area, density, size and 
organisation of the collagen within and between experimental and control wounds. However, 
in contrast to day 6 post-wounding, denser, larger collagen bundles which were arranged 
parallel to the wound surface, (Fig. 3.27) were seen towards the centre of experimental and 
control wounds on day 9 post-wounding, i.e. further from the non-wounded dermis.  It is 
noteworthy that experimental wounds showed significantly greater organisation of collagen 
than control wounds on day 9 post-wounding (Table 3.5). 
 
3.2.4 Histological assessment of wounds on day 15 post-wounding 
By day 15 post-wounding, only one control wound had not completely healed (Table 3.6). In 
the region of this control wound which had not completely re-epithelialised, the epithelium 
and granulation tissue resembled that from similar regions in control wounds on day 9 post-
wounding. In contrast, in regions of the control wounds which had completely re-
epithelialised, the thickness of the new epithelium was less variable on day 15 (Fig. 3.28) 
than on day 9 post-wounding (Figs. 3.22 and 3.23) whereas in experimental wounds the 
thickness of the new epithelium seemed similar on both days. However, the new epithelium 
at the centre of experimental wounds (i.e. at the tip of the epithelial tongue) was significantly 
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thicker than control wounds on day 15 post-wounding (Table 3.6, Figs. 3.28 and 3.29). In 
addition, rete ridges were more numerous and larger in experimental wounds than in the 
control wounds (Figs. 3.28 and 3.29).  Therefore the new epithelium of experimental wounds 
more closely resembled normal skin than did the new epithelium of control wounds.  
 
All layers of the epidermis were present throughout the new epithelium in both the 
experimental and control wounds and the stratum granulosum contained fewer nuclei and was 
seen more clearly than on day 9 post-wounding (Fig. 3.29).  
 
By day 15 post-wounding, arrangement of proliferating keratinocytes within experimental 
wounds more closely resembled that of control wounds. The proliferating keratinocytes were 
arranged in groups and were seen throughout the basal layer of the new epithelium (Fig. 
3.30).  
 
In both experimental and control wounds on day 15 post-wounding, the granulation tissue 
contained fewer fibroblasts, adipocytes and blood vessels than on day 9 post-wounding (Fig. 
3.28). However, on day 15 post-wounding, control wounds appeared to have a greater 
number of blood vessels within the wound area than experimental wounds (Fig. 3.31). In 
contrast, the blood vessels in experimental wounds had a second layer of tissue within the 
vessel wall more frequently than did those in control wounds. However, the blood vessels in 
both wound types had a second layer of tissue in the vessel more frequently on day 15 post-
wounding than on day 9 post-wounding (Table 3.6, Fig. 3.31).  
 
The granulomas seen on day 9 post-wounding which surrounded silver deposits in 
experimental wounds were larger and more numerous on day 15 post-wounding (Figs. 3.28 
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and 3.32). Again, no bacteria were visible within the granulomas on gram staining of the 
experimental sections (Fig. 3.33). In contrast only scattered inflammatory cells were seen in 
the granulation tissue of control wounds (Fig. 3.31).  
 
As on day 9 post-wounding, the collagen within the wound area of both wound types was 
arranged parallel to the epidermis. However, from day 9 to day 15 post-wounding, the 
percentage area of collagen within the control wounds increased, whereas it remained 
constant in the experimental wounds (Table 3.6).  Similarly, for control wounds, the density, 
size and organisation of the collagen bundles increased from day 9 to day 15 post-wounding 
(Fig. 3.34). Surprisingly, in experimental wounds the density, size and organisation of 
collagen bundles decreased from day 9 to day 15 post-wounding (Table 3.6). This decrease 
combined with the increase in size of the collagen bundles in control wounds resulted in the 
size of the collagen bundles in experimental wounds being significantly smaller than in 
control wounds (Table 3.6).  
 
3.2.5 Assessment of healing from day 3 to day 15 post-wounding 
The differences observed between experimental and control wounds on day 3, 6, 9 and 15 
post-wounding were apparent when healing was studied across all of the days post-wounding.  
 
The rate of increase in the area (Fig. 3.35) and length of the epithelial tongue (Fig. 3.36) from 
day 3 to 6 post-wounding was similar in both experimental and control wounds. However, 
between day 6 and 9 post-wounding experimental wounds continued to increase at a constant 
rate whereas the rate of increase in control wounds slowed (Figs. 3.35 and 3.36).  This is 
evident in the differences observed in the epithelial tongues of experimental and control 
wounds on day 9 post-wounding (Figs. 3.22 and 3.23).   
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Similar to the longer rate of increase in the area and length of the epithelial tongue in 
experimental wounds, a higher rate of increase in the thickness of the epithelium at the tip of 
the epithelial tongue was noted from day 9 to day 15 post-wounding in experimental wounds 
when compared to control wounds (Fig. 3.37).  This was apparent in the significantly greater 
thickness of the epithelium within the centre of experimental wounds on day 15 post-
wounding when compared to control wounds (Table 3.6). In addition, the preliminary results 
for the number of proliferating keratinocytes revealed a greater increase in the number of 
proliferating keratinocytes in control wounds when compared to experimental wounds, before 
day 9 post-wounding (Fig. 3.38).  From day 9 to day 15 post-wounding there was a rapid 
increase in the number of proliferating keratinocytes in experimental wounds at a time when 
the numbers of proliferating keratinocytes within control wounds remained constant (Fig 
3.38).  
 
From day 6 post-wounding, the score for the number of blood vessels decreased in 
experimental wounds whereas it continued to increase in control wounds (Fig. 3.39).  In 
contrast, the score for the type of blood vessels increased from day 9 to day 15 post-
wounding, suggesting that experimental wounds contained fewer, more mature blood vessels 
than control wounds on day 15 post-wounding (Fig. 3.40).  
 
The percentage area of collagen (Fig. 3.41) and the scores for the density (Fig. 3.42) and size 
of collagen bundles (Fig. 3.43) increased at a similar rate in both experimental and control 
wounds to day 9 post-wounding.  However, the score for the organisation of collagen in 
experimental wounds had a greater increase between day 6 and 9 post-wounding than control 
wounds (Fig. 3.44). From day 9 post-wounding, the percentage area of collagen and scores 
for size, density and organisation of collagen bundles in experimental wounds decreased 
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whereas in control wounds these parameters continued to increase, although the rate slowed 
(Fig. 3.41- 3.44).  These findings reiterate the significantly greater organisation of collagen 
found in experimental wounds on day 9 post-wounding compared to control wounds as well 
as the significantly greater size in collagen bundles found in control wounds compared to 
experimental wounds on day 15 post-wounding (Tables 3.5 and 3.6).  
 
These findings should be interpreted with caution as different pigs and regions on the dorsum 
of the pig were utilised for assessing healing on day 3, 6, 9 and 15 post-wounding (Table 3.7 
and 3.8). While the Kruskall-Wallis one-way-analysis of variance by ranks showed no 
difference in the weight of the pigs (p=0.54) or the presence of epidermal appendages 
(p=0.57) between the days post-wounding, the assumptions of the ANOVA were not valid 
and therefore the contribution of these factors to differences in the healing of experimental 
and control wounds between different days post-wounding could not be determined. 
 
In summary, the following differences were found between experimental and control wounds.  
 
 Although experimental wounds decreased in area significantly more slowly than 
control wounds, from day 12 post-wounding there was no significant difference in the 
percentage change in area between experimental and control wounds.  
 
 Experimental wounds contained a significantly greater number of inflammatory cells 
on day 3 post-wounding compared to control wounds. In addition, within 
experimental wounds on day 9 and 15 post-wounding, granulomas were seen 
surrounding silver deposits.  
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 While the results are preliminary, a significantly greater number of proliferating 
keratinocytes were found in control wounds than in experimental wounds on day 3 
post-wounding. 
 
 On day 15 post-wounding, the thickness and number of rete ridges within the new 
epithelium of experimental wounds more closely resembled normal skin than did the 
new epithelium in control wounds. The new epithelium within the centre of 
experimental wounds was significantly thicker than in control wounds.  
 
 On day 15 post-wounding, fewer blood vessels were observed in experimental 
wounds as compared to control wounds. In addition, a greater number of more mature 
blood vessels were seen within experimental wounds than in control wounds.  
 
 While the amount of collagen within both wound types was similar on day 15 post-
wounding, the size of the collagen bundles within control wounds was significantly 
greater than in experimental wounds.  
 
Thus, despite a greater inflammatory response in experimental wounds, no difference was 
found in the rate of healing of experimental and control wounds on day 15 post-wounding.  In 
addition, in experimental wounds the blood vessels were more mature and the new epithelium 
more closely resembled normal skin when compared to control wounds on day 15 post-
wounding. Furthermore, smaller collagen bundles and decreases in the organisation, density 
and percentage area of collagen were observed in experimental wounds from day 9 to day 15 
post- wounding compared to control wounds.  
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Table 3.1: Percentage change in wound area for experimental and control wounds 
Note: negative values indicate an increase in wound area 
 
Table 3.2: The Clinical Assessment Scores of the re-epithelialised wounds on day 12 and  
day 15 post-wounding. 
Wound Day Observer A B C D VAS Total 
 
Control 1 
 
12 
1 3 2 1 2 3.5 11.5 
2 2 1 2 3 3 11 
3 2 2 2 2 4 12 
 
Control 2 
 
12 
1 3 1 2 1 3.5 10.5 
2 4 1 2 2 3 12 
3 3 1 2 2 5 13 
 
Control 1 
 
15 
1 3 1 1 2 3.9 10.9 
2 3 1 2 2 2.4 10.4 
3 2 1 2 1 3 9 
 
Control 2 
 
15 
1 3 2 1 1 4 11 
2 4 2 1 1 2 10 
3 3 2 1 1 4 11 
 
Experimental  
 
15 
1 4 1 1 1 3.6 10.6 
2 4 1 1 1 2.3 9.3 
3 2 1 2 1 3 9 
 Experimental wound 
Median  
(Minimum: 
Maximum) 
Control wound 
Median  
(Minimum: 
Maximum) 
p  
(Mann Whitney U 
test) 
Wound area on day 0 post-
wounding (mm) 
94.00 
(31.00: 123.00) 
96.50 
(41.00: 147.00) 
0.66 
Day 0 to day 3 post-
wounding  
-47.00  
(-202.00: 13.00) 
-7.00  
(-80.00: 35.00) 
0.001 
Day 0 to day 6 post-
wounding   
-25.00 
(-94.00: 19.00) 
0.00 
 (-110.00: 33.00) 
0.04 
Day 0 to day 9 post-
wounding   
31.50  
(-36.00: 91.00) 
63.00  
(25.00: 92.00) 
0.04 
Day 0 to day 12 post-
wounding   
83.00  
(46.00: 98.97) 
97.00  
(77.00: 100.00)  
0.310 
Day 0 to day 15 post-
wounding  
83.00  
(73.00: 100.00)  
98.29  
(80.00: 100.00)  
0.31 
A: Colour, B: matte/ shiny, C: Contour; D: Distortion  
VAS: Visual analogue scale: 10 indicates a poor scar, 0 indicates a good scar. 
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Table 3.3: Median values for histological measurements on day 3 post-wounding 
 
  
 Experimental wound 
Median  
(Minimum: 
Maximum) 
Control wound 
Median  
(Minimum: 
Maximum) 
p  
(Mann Whitney U 
test) 
Area of the epithelial 
tongue (µm
2
) 
82324.72  
(58001.89:128672.80) 
61420.48  
(40090.70:88520.06) 
0.14 
Length of the epithelial 
tongue (µm) 
1565.04  
(1283.34: 2215.80 ) 
1347.27  
(1070.54: 1470.41) 
0.09 
Thickness of the 
epithelium at the  
wound edge (µm) 
96.28  
(87.38:117.84 ) 
92.22  
(50.27: 99.23) 
0.30 
Thickness of the 
epithelium at the tip of the 
epithelial tongue (µm) 
52.93  
(42.85: 71.56 ) 
38.31  
(32.60: 55.80 ) 
0.09 
Score for epidermal 
appendages 
0.83 
 (0.33: 0.83) 
0.83 
 (0.33: 0.83) 
0.92 
Number of proliferating 
keratinocytes 
4.67  
(1.33: 7.00) 
9.33  
(7.00: 26.00) 
0.02 
Number of inflammatory 
cells 
314.78  
(232.78: 373.22) 
120  
(54.56: 147.00) 
0.01 
Score for  
blood vessel type 
0 
 (0: 0) 
0  
(0: 0) 
0.92 
Score for  
blood vessel number 
0  
(0: 0) 
0 
(0: 0) 
0.92 
Percentage area of collagen 
(µm
2
) 
2.65  
(0.84: 5.23) 
0.53 
 (0.17: 1.96) 
0.06 
Score for collagen density 0 
 (0: 0) 
0  
(0: 0) 
0.92 
Score for collagen  
bundle size 
0 
 (0: 0) 
0 
 (0: 0) 
0.92 
Score for collagen 
organisation 
0  
(0: 0) 
0  
(0: 0) 
0.92 
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Table 3.4: Median values for histological measurements on day 6 post-wounding 
 Experimental 
wound 
Median  
(Minimum: 
Maximum) 
Control wound 
Median  
(Minimum: 
Maximum) 
p  
(Mann Whitney U 
test) 
Area of the epithelial 
tongue (µm
2
) 
424848.10 
 (204293.80: 
530267.50) 
495958.60 
 (363205.70: 
673859.70) 
0.53 
Length of the epithelial 
tongue (µm) 
5061.80 
(3047.00: 6002.10) 
5881.10  
(4209.00: 8693.30) 
0.30 
Thickness of the epithelium 
at the  
wound edge (µm) 
147.57  
(92.78:192.39) 
129.29  
(103.57:159.85) 
0.53 
Thickness of the epithelium 
at the tip of the epithelial 
tongue (µm) 
72.89 
 (61.39:110.63) 
58.57  
(53.18: 65.60) 
0.09 
Score for epidermal 
appendages 
0.67  
(0.33: 0.83)  
0.67  
(0.50: 0.83) 
1.00 
Number of proliferating 
keratinocytes 
8.00  
(0.00: 13.33) 
25.67  
(8.33: 100.33) 
0.09 
Number of inflammatory 
cells 
39.44 
 (26.78: 174.44) 
96.67 
 (29.89: 142.89) 
0.83 
Score for  
blood vessel type 
1.00 
(1.00: 1.00) 
1.00 
 (1.00: 1.33) 
0.35 
Score for  
blood vessel number 
1.83 
 (1.00: 2.00) 
1.83 
 (1.33: 2.67) 
0.46 
Percentage area of collagen 
(µm
2
) 
12.22  
(6.10: 22.85) 
18.61  
(3.45: 43.20) 
0.68 
Score for collagen density 0.58  
(0.17: 1.67) 
0.92  
(0.08: 2.00) 
0.83 
Score for collagen  
bundle size 
1.25 
 (0.92: 1.67) 
1.50 
 (1.00: 2.00) 
0.30 
Score for collagen 
organisation 
0.92  
(0.58: 1.25) 
1.0  
(0.25: 1.83) 
0.60 
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Table 3.5: Median values for histological measurements on day 9 post-wounding  
 Experimental wound 
Median  
(Minimum: 
Maximum) 
Control wound 
Median  
(Minimum: 
Maximum) 
p  
(Mann Whitney U 
test) 
Size of the epithelial gap 
(µm) 
1431.55  
(868.66: 1575.74) 
1159.18  
(0.00: 2615.38) 
0.53 
Percentage by which the 
wound has closed 
70.43  
(64.39: 81.39) 
69.58  
(53.58: 100.00) 
1.0 
Width of the wound area 
(µm) 
4095.105 
(3484.32: 4663.460) 
3048.418 
(2660.75: 5365.21) 
0.14 
Area of the epithelial 
tongue or new epithelium 
(µm
2
) 
989659.20  
(618998.60: 
1181906.00) 
640817.60  
(393321.60: 
790971.80) 
0.09 
Length of the epithelial 
tongue (µm) 
8691.20 
(6034.60: 9223.00) 
7016.20  
(3887.50: 8070.50) 
0.14 
Thickness of the epithelium 
at the  
wound edge (µm) 
158.61  
(130.19: 174.30) 
204.90  
(151.30: 251.26) 
0.14 
Thickness of the epithelium 
at the tip of the epithelial 
tongue (µm) 
86.31 
 (73.12: 96.02) 
91.83 
 (36.95: 135.43) 
1.00 
Score for epidermal 
appendages 
0.67  
(0.17: 1.00) 
0.67  
(0.67: 1.00) 
0.83 
Number of proliferating 
keratinocytes 
8.33  
(0.00: 39.00) 
31.33  
(8.33: 65.33) 
0.17 
Number of inflammatory 
cells 
19.89  
(13.44: 27.67) 
36.78  
(17.11: 44.33) 
0.09 
Score for  
blood vessel type 
1.33  
(1.17: 2.00) 
1.50  
(1.17: 1.83) 
0.75 
Score for  
blood vessel number 
1.50  
(1.50: 2.33) 
2.00 
 (1.17: 2.33) 
0.46 
Percentage area of collagen 
(µm
2
) 
45.67  
(41.68: 60.86) 
43.55  
(24.93: 59.55) 
0.40 
Score for collagen density 2.17 
 (1.83: 2.75) 
2.17 
 (1.50: 2.33) 
0.40 
Score for collagen  
bundle size 
2.33  
(2.00: 2.33) 
2.08 
 (1.92: 2.25) 
0.21 
Score for collagen 
organisation 
1.75  
(1.50: 2.17) 
1.42  
(1.00: 1.67) 
0.04 
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Table 3.6: Median values for histological measurements on day 15 post-wounding 
 Experimental wound 
Median  
(Minimum: 
Maximum) 
Control wound 
Median  
(Minimum: 
Maximum) 
p  
(Mann Whitney U 
test) 
Size of the epithelial gap 
(µm) 
0  
(0: 0) 
0  
(0: 819.95) 
0.68 
Percentage by which the 
wound has closed 
100  
(100: 100) 
100  
(78.91: 100) 
0.68 
Width of the wound area 
(µm) 
2112.36 
(1279.21: 2387.66)  
1717.733 
(1205.75: 3048.87) 
0.83 
Area of the epithelial 
tongue (µm
2
) 
377299.40  
(218576.10: 
589713.40) 
191806.90  
(146321.30: 
303423.10) 
0.09 
Length of the epithelial 
tongue (µm) 
3931.90  
(2457.30: 4392.40) 
2860.90  
(2262.40: 4752.20) 
0.53 
Thickness of the epithelium 
at the  
wound edge (µm) 
141.93  
(73.81: 221.80) 
119.41  
(107.03: 166.20) 
0.40 
Thickness of the epithelium 
at the tip of the epithelial 
tongue (µm) 
146.83  
(125.65: 200.47) 
83.32  
(79.01: 140.51) 
0.04 
Score for epidermal 
appendages 
0.50 
 (0.33: 0.83) 
0.83 
 (0.50: 1.00) 
0.14 
Number of proliferating 
keratinocytes 
39.67  
(6.33: 78.00) 
31.00  
(1.33: 74.00) 
0.68 
Number of inflammatory 
cells 
8.67  
(3.89: 18.33) 
14.67  
(12.00: 35.11) 
0.14 
Score for  
blood vessel type 
1.83  
(1.83: 2.00) 
1.67  
(1.33: 1.83) 
0.06 
Score for  
blood vessel number 
1.00  
(1.00: 1.17) 
1.17 
 (1.00: 1.50) 
0.40 
Percentage area of collagen 
(µm
2
) 
46.39  
(24.25: 61.08) 
54.47  
(39.20: 65.71) 
0.30 
Score for collagen density 1.83  
(1.25: 2.42) 
2.25  
(1.92: 2.58) 
0.14 
Score for collagen  
bundle size 
2.00  
(2.00: 2.25) 
2.42  
(2.17: 2.50) 
0.03 
Score for collagen 
organisation 
1.42  
(1.17: 1.83) 
1.67  
(1.17: 1.83) 
0.75 
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Table 3.7: Contingency table indicating the regions on the dorsum of the pigs utilized on each 
day post-wounding  
Day  
post-
wounding 
Towards  
the head 
Middle  Towards  
the tail 
Total*  
(experimental and  
control wounds) 
3 0 4 6 10 
6 4 2 4 10 
9 4 4 2 10 
15 6 2 2 10 
*Total number of experimental and control wounds 
 
Table 3.8: Contingency table indicating the pigs utilized on each day post-wounding  
Day  
post-
wounding 
Pig 1 Pig 2 Pig 3 Pig 4 Pig 5 Pig 6 Pig 7 Pig 8 Pig 9 Total* 
3 0 0 2 2 2 0 2 2 0 10 
6 0 0 2 2 2 0 2 2 0 10 
9 0 0 2 2 2 2 0 0 2 10 
15 0 0 0 2 0 0 0 0 8 10 
*Total number of experimental and control wounds 
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Figure 3.1 Representative photographs of experimental (A-F) and control wounds (G-L) on 
the day of wound creation (A, G) and on day 3 (B, H), day 6 (C, I), day 9 (D, J),  
day 12 (E, K) and day 15 (F, L) post-wounding. Note the erythema surrounding the 
experimental wound on day 3 (B) and the control wound on day 6 (I). The solid arrows 
indicate small amounts of exudate visible on the control wounds on day 6 (I) and day 9 (J). 
The dotted arrows indicate areas of new epithelium. Black scabs, discoloured by the silver, 
are present on experimental wounds on day 12 (E) and day 15 (F). Discolouration of the hair 
in experimental wounds is particularly noticeable on day 15 (F).  
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Figure 3.2 Photographs of experimental (A, B) and control (C-F) wounds utilised for the 
Clinical Assessment Score on day 12 (A, C, E) and day 15 (B, D, F) post-wounding. Note B-
F are re-epithelialised and A is not. 
 
A 
C 
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B 
D 
F 
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Figure 3.3 Representative photomicrographs of experimental (A) and control (B) wounds on day 3 post-wounding illustrating the new 
epithelium (solid arrow) extending into the wound area and the fibrin clot (*) adjacent to the dermis (D) and hypodermis (HD). Note the longer 
epithelium tongue (solid arrows) on the left of the experimental wound (A) when compared to the control wound (B). However, the epithelial 
tongue on the right of the experimental wound (A) is shorter than the left, illustrating the variability in experimental wounds. The amount of 
fibrin clot (*) is greater in control wounds (B). Areas of inflammatory infiltrate within experimental (A) and control (B) wounds are also visible 
(dashed arrows). Note: images have been merged to create a composite image. (H&E)   
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Figure 3.4 Representative photomicrographs of epithelial tongues in experimental (A) and control (B) wounds on day 3 post-wounding 
illustrating the longer and thicker epithelial tongue seen in experimental wounds. The tips of each epithelial tongue are indicated by the solid 
arrows. Note that the epithelial tongue in the experimental wound (A) contains a rete ridge (dashed arrow).  All layers of the epidermis, 
including the stratum corneum (sc) are visible at the wound edge in both experimental (A) and control wounds (B). The greater inflammatory 
response in the experimental wound (A) is also visible. Note: images have been merged to create a composite image. (H&E) 
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Figure 3.5 Representative photomicrographs of the tips of epithelial tongues in experimental (A) and control (B) wounds on day 3 post-
wounding. This illustrates the greater number of cell layers in the tip of the epithelial tongue of experimental wounds (A) and the lack of 
differentiation of the epithelium in both wound types. (H&E, 20X magnification) 
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Figure 3.6 Representative photomicrographs of proliferating keratinocytes in the epithelium of experimental (A) and control (B) wounds on day 
3 post-wounding. The positive control (C: human tonsil) and negative control (D: an adjacent section to A) are also shown.  Arrows indicate 
examples of the nuclei of proliferating cells immunolabelled for Ki-67. Note the single cell within a rete ridge of non-wounded epithelium in the 
experimental wound (A) compared to the greater number of cells which are situated within the basal layer of the epithelial tongue in the control 
wound (B). The dotted line in D indicates the position of the epidermal-dermal junction.  (Immunocytochemical labelling for Ki-67, DIC 
microscopy, 25X magnification)  
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Figure 3.7 Representative photomicrographs of a fibrin clot in experimental (A) and control (B) wounds on day 3 post-wounding illustrating the 
greater inflammatory response in the experimental wound (A). ‘a’ indicates an adipocyte. rbc indicates red blood cells within the fibrin clot. 
Note the lack of blood vessels or collagen in both wound types. (H&E, 20X magnification)  
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Figure 3.8 Representative photomicrographs of fibrin clot in experimental (A) and control (B) wounds on day 3 post-wounding, illustrating the 
absence of bacteria. Long arrows in A and B indicate examples of inflammatory cell nuclei. C is the positive control in which gram positive 
bacilli can be seen (short arrows). (Gram stain, 63X magnification) 
 
  
  
8
1
 
 
Figure 3.9 Representative photomicrographs of the wound area of experimental (A) and control (B) wounds on day 3 post-wounding illustrating 
the lack of collagen within the wound area. * indicates an area of normal collagen in the control wound (B). Note the silver particle (arrow) in 
the experimental wound (A). (Picrosirius red stain, confocal microscopy, 25X magnification) 
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Figure 3.10 Representative photomicrograph showing deposits of silver (solid arrows) within the wound area of an experimental wound on day 3 
post-wounding. * indicates an area of normal collagen. (Picrosirius red stain, confocal microscopy, 25X magnification) 
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Figure 3.11 Representative photomicrographs of experimental (A) and control (B) wounds on day 6 post-wounding illustrating the longer and 
thicker epithelial tongues (solid arrows) in the control wound. Note the larger rete ridges (dashed arrows) of the new epithelium (solid arrows) 
within the control wound (B).  * indicates the granulation tissue which fills the wound area of both wound types and in which adipocytes (a) can 
be seen. bv indicates new blood vessels within the control wound (B). D: non-wounded dermis, HD: hypodermis. Note: images have been 
merged to create a composite image.   (H&E)    
  
8
4
 
 
Figure 3.12 Representative photomicrographs of epithelial tongues in experimental (A) and control (B) wounds on day 6 post-wounding. The 
tips of each epithelial tongue are indicated by the thick, solid arrows. While rete ridges (dashed arrows) are seen in both wound types, the 
epithelial tongue of the control wound (B) is longer and thicker than that of the experimental wound (A) and also contains a greater number of 
rete ridges.  The stratum corneum (sc) can be seen extending down the epithelial tongues of both wound types. In addition, a blood vessel (bv) 
can be seen in the control wound (B).  Note: images have been merged to create a composite image. (H&E).  
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Figure 3.13 Representative photomicrographs of tips of epithelial tongues (outlined by the dotted lines) in experimental (A) and control (B) 
wounds on day 6 post-wounding illustrating the greater number of cell layers in the experimental wound (A).  (H&E, 20X magnification) 
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Figure 3.14 Representative photomicrographs of proliferating keratinocytes in the epithelium of experimental (A) and control (B) wounds on day 
6 post-wounding. The positive control (C: human tonsil) and negative control (D: an adjacent section to B) are also shown. Arrows indicate 
examples of the nuclei of proliferating cells immunolabelled for Ki-67.  Note the cluster of Ki-67 labelled cells within the control wound (B) 
compared to the single cells within the experimental wound (A). The dotted line in D indicates the position of the epidermal-dermal junction. 
(Immunocytochemical labelling for Ki-67, DIC microscopy, 25X magnification)   
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Figure 3.15 Representative photomicrographs of granulation tissue in experimental (A) and control (B) wounds on day 6 post-wounding 
illustrating blood vessels (bv) with a single layer of cells in the vessel wall  and areas of new collagen deposition (short arrows) in both wound 
types. ‘a’ indicates adipocytes. The thin arrows indicate the nuclei of scattered inflammatory cells while the long, thick arrows illustrate 
fibroblast nuclei. (H&E, 20X magnification)   
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Figure 3.16 Representative photomicrographs of collagen within the wound area of experimental (A) and control (B) wounds on day 6 post-
wounding illustrating small collagen bundles (arrows) which are not densely arranged nor organised. (Picrosirius red stain, confocal microscopy, 
25X magnification). 
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Figure 3.17 Representative photomicrographs of the epithelial tongue in experimental (A) and control (B) wounds which have not re-
epithelialised by day 9 post-wounding. Note the stratum corneum (sc) visible on the epithelial tongue at variable distances from the wound edge 
and the thinner epithelium within the control wounds (B) when compared to experimental wounds (A). Dashed arrows indicate rete ridges. The 
solid arrows indicate the tip of epithelial tongue. Note: images have been merged to create a composite image. (H&E).   
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Figure 3.18 Representative photomicrographs of the tip of the epithelial tongue (outlined by the dotted line) in experimental (A) and control (B) 
wounds which had not re-epithelialised by day 9 post-wounding illustrating the undifferentiated nature of the epithelium.   
(H&E, 20X magnification) 
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Figure 3.19 Representative photomicrographs of the new epithelium in re-epithelialised experimental (A) and control (B) wounds on day 9 post-
wounding. Note the stratum corneum (sc) visible throughout the new epithelium of both wound types. Dashed arrows indicate rete ridges. Note: 
images have been merged to create a composite image. (H&E)  
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Figure 3.20 Representative photomicrographs of new epithelium from the re-epithelialised experimental (A) and control (B) wounds as well as 
the epithelium of normal porcine skin (C) on day 9 post-wounding. Note the stratum corneum (sc) and stratum basale (visible above the dotted 
line) present in both experimental and control wounds. Increased numbers of nuclei (arrows) can be seen in the stratum corneum (sc) and stratum 
granulosum (sg) of the wounded epidermis (A and B) when compared to normal epidermis (C). (H&E, 20X magnification)   
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Figure 3.21 Representative photomicrographs of proliferating keratinocytes in the epithelium of experimental (A) and control (B) wounds on day 
9 post-wounding. The positive control (C: human tonsil) and negative control (D: an adjacent section to B) are also shown. Arrows indicate 
examples of the nuclei of proliferating cells immunolabelled for Ki-67.  Note the cluster of Ki-67 labelled cells within the control wound (B) 
compared to the single cells within the experimental wound (A). The dotted line in D indicates the position of the epidermal-dermal junction. 
Arrows indicate examples of the nuclei of proliferating cells immunolabelled for Ki-67.  (Immunocytochemical labelling for Ki-67, DIC 
microscopy, 25X magnification)    
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Figure 3.22 Representative photomicrographs of experimental (A) and control (B) wounds which have not re-epithelialised by day 9 post-
wounding illustrating granulation tissue (*) within the wound area. The dashed arrows indicate areas of inflammatory cell infiltrates.  
a: adipocytes D: dermis  HD: hypodermis. Note: images have been merged to create a composite image.  (H&E)  
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Figure 3.23 Representative photomicrographs of re-epithelialised experimental (A) and control (B) wounds on day 9 post-wounding. The circles 
indicate areas of inflammatory cell infiltrates associated with silver deposits in the experimental wound (A). a: adipocytes D: dermis   
HD: hypodermis. Note: images have been merged to create a composite image.  (H&E)   
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Figure 3.24 Representative photomicrographs of granulation tissue from experimental (A and C) and control (B and D) wounds on day 9 post-
wounding. Photomicrographs A and B are from wounds which have not re-epithelialised and illustrate the greater inflammatory response 
compared to wounds which had re-epithelialised (C and D). Thin arrows indicate inflammatory cell nuclei. Blood vessels (bv) are seen in both 
wound types. Fibroblasts (thick arrows) and areas of collagen (short arrows) are also visible. (H&E, 20X magnification)   
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Figure 3.25 Representative photomicrograph of a granuloma in an experimental wound on day 9 post-wounding. * indicates a giant cell; thin 
arrows indicate inflammatory cell nuclei and thick arrows indicate epithelioid cells. (H&E, 20X magnification) 
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Figure 3.26 Representative photomicrograph of a granuloma in an experimental wound on day 9 post-wounding illustrating the absence of 
bacteria. Small arrows indicate examples of inflammatory cell nuclei. The large arrow indicates a piece of silver.  An example of smaller pieces 
of silver is circled. (Gram stain, 63X magnification)  
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Figure 3.27 Representative photomicrographs of collagen within the wound area of experimental (A) and control (B) wounds on day 9 post-
wounding illustrating medium sized collagen bundles. Note in the experimental wound (A) the collagen bundles are arranged in parallel whereas 
the collagen is less organised in the control wound (B). (Picrosirius red stain, confocal microscopy, 25X magnification).   
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Figure 3.28 Representative photomicrographs of re-epithelialised experimental (A) and control (B) wounds on day 15 post-wounding. Note the 
thicker new epithelium (solid arrow) and larger rete ridges (dashed arrow) within the experimental wound (A).  Within the granulation tissue (*) 
of the experimental wound (A), an inflammatory cell infiltrate associated with silver particles (circled) can be seen at the level of the lower 
dermis (D) and hypodermis (HD). Note: images have been merged to create a composite image. (H&E).   
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Figure 3.29 Representative photomicrographs of new epithelium at the centre of the wound in re-epithelialised experimental (A) and control (B) 
wounds on day 15 post-wounding. Image C is a representative photomicrograph of normal skin. Note the thicker epithelium with larger and 
more numerous rete ridges (dashed arrows) in the experimental wound. In addition, all layers of the epidermis, including the stratum corneum 
(sc), stratum granulosum (sg) and stratum basale (sb), can be seen in both experimental (A) and control wounds (B). (H&E, 20Xmagnification)   
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Figure 3.30 Representative photomicrographs of proliferating keratinocytes in the epithelium of experimental (A) and control (B) wounds on day 
15 post-wounding. The positive control (C: human tonsil) and negative control (D: an adjacent section to B) are also shown. Arrows indicate 
examples of the nuclei of proliferating cells immunolabelled for Ki-67.  The dotted line in D indicates the position of the epidermal-dermal 
junction. (Immunocytochemical labelling for Ki-67, DIC microscopy, 25X magnification)  
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Figure 3.31 Representative photomicrographs of granulation tissue from experimental (A) and control (B) wounds on day 15 post-wounding. 
Blood vessels (bv) with two layers of tissue within the vessel wall are seen in both wound types, although blood vessels of all types are more 
numerous in control (B) wounds. Fibroblasts (thick arrows) and areas of collagen (short arrows) are also visible.  (H&E, 20X magnification)   
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Figure 3.32 Representative photomicrograph of a granuloma in an experimental wound on day 15 post-wounding. * indicates a giant cell; thin 
arrows indicate inflammatory cell nuclei and thick arrows indicate epithelioid cells.  (H&E, 25X magnification). 
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Figure 3.33 Representative photomicrograph of a granuloma in an experimental wound on day 15 post-wounding illustrating the absence of 
bacteria. The large arrow indicates a piece of silver. Examples of smaller pieces of silver are circled. (Gram stain, 63X magnification) 
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Figure 3.34 Representative photomicrographs of collagen within the wound area of experimental (A) and control (B) wounds on day 15 post-
wounding illustrating larger collagen bundles in control wounds (arrows). (Picrosirius red stain, confocal microscopy, 25X magnification). 
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Figure 3.35 Graph of the median values of the area of the epithelial tongue for each day post-
wounding. Note the greater increase in the area of the epithelial tongue in experimental 
wounds (seen in the slope of the graph) from day 6 to day 9 post-wounding.  
 
 
Figure 3.36 Graph of the median values of the length of the epithelial tongue for each day 
post-wounding. Note the greater increase in the length of the epithelial tongue in 
experimental wounds (seen in the slope of the graph) from day 6 to day 9 post-wounding.  
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Figure 3.37 Graph of the median values of the thickness of the tip of the epithelial tongue for 
each day post-wounding. Note the greater increase in the thickness of the tip of the epithelial 
tongue in experimental wounds (seen in the slope of the graph) from day 9 to day 15 post-
wounding.  
 
 
Figure 3.38 Graph of the median values for the number of proliferating keratinocytes for each 
day post-wounding. Note the greater increase in the number of proliferating keratinocytes in 
control wounds (seen in the slope of the graph) from day 3 to day 9 post-wounding.  
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Figure 3.39 Graph of the median values for the score for the number of blood vessels for each 
day post-wounding.  
 
 
Figure 3.40 Graph of the median values for the score for the type of blood vessels for each 
day post-wounding.  
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Figure 3.41 Graph of the median values of the percentage area of collagen for each day post-
wounding. Note the decrease in experimental wounds from day 9 to day 15 post-wounding. 
 
 
Figure 3.42 Graph of the median values of the score for the density of collagen for each day 
post-wounding. Note the decrease in experimental wounds from day 9 to day 15 post-
wounding. 
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Figure 3.43 Graph of the median values of the score for the size of collagen bundles for each 
day post-wounding. Note the decrease in experimental wounds from day 9 to day 15 post-
wounding. 
 
 
Figure 3.44 Graph of the median values of the score for the organisation of collagen bundles 
for each day post-wounding. Note the decrease in experimental wounds from day 9 to day 15 
post-wounding. 
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4. DISCUSSION 
No clinically relevant difference in the rate of wound closure was found in the present study 
between acute excisional wounds treated with nanocrystalline silver (Acticoat
TM
) and those 
treated with polyurethane film dressings (Opsite
TM
). However, the results suggest that 
nanocrystalline silver may improve epithelial restoration resulting in new epithelium which 
more closely resembles normal epidermis. In addition, nanocrystalline silver stimulates the 
formation of more mature blood vessels and modulates the deposition of the extracellular 
matrix, effects which have an impact on the functional and aesthetic properties of scars 
(Reinke and Sorg, 2012; DiPietro, 2013).  
 
In the current study, there was no significant difference in the percentage change in wound 
area between experimental and control wounds from day 12 post-wounding. However, all 
four of the experimental wounds and two of the three control wounds in which complete re-
epithelialisation was not observed on day 15 post-wounding, were covered by adherent scabs. 
The area of the scab could falsely decrease the value of the percentage change in area and the 
wounds could be re-epithelialised beneath the scabs. Indeed, histological assessment on day 
15 post-wounding revealed that re-epithelialisation was complete in all of the regions 
sampled from the experimental wounds. In comparison, a single control wound had one 
region which was not completely re-epithelialised on day 15 post-wounding. As no 
significant differences were found in the macroscopic and histological assessments of wound 
closure on day 15 post-wounding or on observation, there was no clinically relevant 
difference in the rate of wound closure between acute excisional wounds treated with 
nanocrystalline silver and those treated with polyurethane film dressings.  
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This contrasts with previous studies investigating the effect of silver nanoparticles on healing 
in acute, uncontaminated full-thickness wounds, which mostly report increased rates of 
healing (Burd et al., 2007; Liu et al., 2010; Arican et al., 2012; Prestes et al., 2012). The 
investigated dressings included Acticoat
TM
 which was applied every three (Burd et al., 2007) 
or seven days (Arican et al., 2012; Prestes et al., 2012) as well as a dressing containing 
0.04mg/cm2 of silver nanoparticles that was applied daily (Liu et al., 2010). Therefore, 
differences in the silver concentration or the time for which the dressings were applied are 
unlikely to account for the different results. However, in contrast to the current study, these 
previous studies were all undertaken in rodent models (Burd et al., 2007; Liu et al., 2010; 
Arican et al., 2012; Prestes et al., 2012). Wound contraction plays a greater role in healing in 
rodents than in pigs (Sullivan et al., 2001). As silver nanoparticles increase the differentiation 
of myofibroblasts (Liu et al., 2010) they may affect the rate of wound contraction. Thus, 
variations in healing between rodents and pigs may account for the observed differences in 
the rate of healing.  
 
In the current study, a significantly greater inflammatory response was found on day 3 post-
wounding in experimental wounds as compared to control wounds. As no bacteria were 
visible in the experimental or control wounds, infection was unlikely in either type of wound 
(Edwards and Harding, 2004). This suggests that the silver nanoparticles or silver ions 
released from Acitcoat
TM
 were responsible for the increased inflammatory response in 
experimental wounds. This finding of the present study contrasts strongly with the literature 
which reports anti-inflammatory effects of silver nanoparticles in pig and mouse models of 
contact dermatitis (Bhol and Schechter, 2005; Nadworny et al., 2008; Nadworny et al., 
2010), in a mouse burn wound model (Tian et al., 2007) and in contaminated full-thickness 
wounds in pigs (Wright et al., 2002). Acticoat
TM
 (Wright et al., 2002; Nadworny et al., 2008) 
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as well as other silver nanoparticle formulations (creams and solutions) and concentrations 
(Bhol and Schechter, 2005; Tian et al., 2007; Nadworny et al., 2010) were investigated in 
these studies.  Therefore, the decreased inflammatory response, reported in the latter studies 
as compared to the present study, are unlikely to be due to differences in the delivery vehicle 
or silver nanoparticle concentration alone. However, in the latter studies the dressings were 
changed daily. This contrasts with the current study, in which the dressings were changed 
every three days, and may account for the different inflammatory response seen.  
 
In addition, differences in healing between wound models (Davidson, 1998) as well as 
differences in inflammatory cell activation may explain the disparate inflammatory response 
noted in the current analysis. In acute wounds, macrophage activation is not dependent on T-
cell interaction (Gordon, 2002). On the contrary, in contact dermatitis TH1 and CD8
+
 T cells 
are vital for the initiation of the inflammatory response and stimulation of macrophages 
(Kimber and Dearman, 2002). In vitro studies have shown that macrophages in different 
states of activation respond differently to silver nanoparticles. Human macrophages cultured 
with silver nanoparticles showed decreased cell viability at concentrations of 10ppm when 
stimulated with phytohaemagglutinin (PHA) compared to 15ppm when not stimulated by 
PHA (Shin et al., 2007). In addition, the secretion of IL6 by mouse macrophages in response 
to toll-like receptor ligands differs if cells are pre-treated with or simply cultured with 
tiopronin-protected silver nanoparticles (Castillo et al., 2008).  
 
However, in vivo studies on silver nanoparticle-treated acute, uncontaminated, full-thickness 
excisional wounds in rodent models, either do not comment on the level of inflammation in 
the wound (Burd et al., 2007; Liu et al., 2010) or do not investigate the early phase of healing 
(Arican et al., 2012; Prestes et al., 2012). Similar to the results of the present study, no 
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difference was found in the inflammatory response of Acticoat
TM
-treated uncontaminated 
full-thickness wounds compared to control wounds (distilled water) from day 7 to day 21 
post-wounding in a rat model (Prestes et al., 2012). In contrast, Arican et al (2012) described 
sterile abscesses in Acticoat
TM
-treated uncontaminated full-thickness wounds in a rabbit 
model on day 7 and 14 post-wounding. When considered with the results of Arican et al 
(2012), the results of the current study suggest that Acticoat
TM
 may induce inflammation in 
acute wounds. In addition, Arican et al (2012) and Prestes et al (2012) describe the presence 
of giant cells in the Acticoat
TM
-treated wounds on day 14 and 21 post-wounding. This is 
similar to the giant cells associated with silver deposits on day 9 and 15 post-wounding 
observed in the current study. Silver deposits have been described previously at the level of 
the lower dermis in skin wounds treated with silver (Fredriksson et al., 2009; Wang et al., 
2009). However, the only additional report of granulomatous lesions was in the lungs of rats 
exposed to silver nanoparticles (18-19nm) via inhalation for 13 weeks (Sung et al., 2009). 
Thus, the findings of this study along with those of Arican et al (2012) and Prestes et al 
(2012) suggest that prolonged exposure to silver can induce a foreign body chronic 
inflammatory reaction, an important consideration as chronic inflammation stimulates 
scarring (Reinke and Sorg, 2012).  
 
The increased inflammatory response on day 3 post-wounding may also account for the 
significantly greater increase in the percentage change in wound area in experimental wounds 
as compared to control wounds on the same day. Increased vascular permeability, due to the 
inflammatory response, causes oedema (DiPietro, 2013). This swelling results in wound 
expansion (McGrath and Kersey, 2009) causing an apparent increase in the wound area 
unrelated to wound closure. Similarly, residual oedema from the increased inflammatory 
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response in experimental wounds on day 3 post-wounding may be a contributing factor to the 
slower decrease in the wound area of experimental wounds on day 6 and 9 post-wounding.  
 
Differences in ECM remodelling and wound contraction are an additional consideration. 
Fibrin clot stimulates fibroblast migration and proliferation (Greaves et al., 2013). Therefore, 
the greater amount of fibrin clot in control wounds on day 3 post-wounding may initiate 
earlier remodelling of the ECM, decreasing the wound area. Furthermore, no significant 
differences were found in the measures of epithelial restoration between experimental and 
control wounds on day 3, 6 or 9 post-wounding. This suggests that the differences in the 
percentage change in wound area were not due to differences in re-epithelialisation, but rather 
the inflammatory response or differences in wound contraction.  
 
However, the current study does show that Acticoat
TM
 influenced re-epithelialisation by 
affecting the proliferation of keratinocytes. The decreased number of proliferating 
keratinocytes in experimental wounds on day 3, 6 and 9 post-wounding could be due to silver 
nanoparticle-induced cell cycle arrest, similar to in vitro findings (Zanette et al., 2011). A cell 
arrested in the G2/M or S phase of the cell cycle would be positively labelled for Ki-67 
(Gerdes et al., 1984). Thus, the presence of single positively labelled cells in the epithelium 
of experimental wounds on day 3, 6 and 9 post-wounding is consistent with keratinocytes that 
have entered but not completed the cell cycle. Moreover, the clusters of positively labelled 
cells noted in the epithelium of control wounds on the same days post-wounding would be 
consistent with cells that have recently completed cell division.  
 
Of note, a considerable increase in the number of proliferating keratinocytes was observed 
from day 9 to day 15 post-wounding in experimental wounds. This increase was accompanied 
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by a change in the arrangement of positively-labelled cells in the epithelium of experimental 
wounds from single cells to clusters indicative of cells completing cell division. The different 
proliferation response of keratinocytes to silver nanoparticles on day 3 and day 15 post-
wounding may be due to a decrease in the concentration of silver nanoparticles as healing 
progresses. In larger wounds, such as those on day 3 post-wounding, cells are exposed to a 
greater amount of silver (Lansdown and Williams, 2004; Larese et al., 2009). As the wound 
area decreases, as occurs from day 9 to day 15 post-wounding in the current study, cells in 
the healed regions of the wound are exposed to less silver, which must diffuse through intact 
epithelium to reach the cells (Larese et al., 2009). The effects of silver nanoparticles on 
keratinocytes and fibroblasts are concentration dependent (AshaRani et al., 2009; Greulich et 
al., 2009; Samberg et al., 2010; Hackenberg et al., 2011; Zanette et al., 2011). As fibroblasts 
affect keratinocyte proliferation and migration (Werner et al., 2007), lower concentrations of 
silver nanoparticles would not only directly decrease the inhibition of keratinocyte 
proliferation but also have indirect effects through fibroblast-keratinocyte interactions. Liu et 
al (2010) also reported increased immunolabelling for proliferating cell nuclear antigen in 
keratinocytes of silver nanoparticle-treated excisional wounds compared to untreated control 
wounds in mice on day 15 post-wounding. Unfortunately, results before day 15 post-
wounding were not clearly reported. Therefore the effect of silver nanoparticles on 
keratinocyte proliferation in earlier wounds cannot be compared.  
 
However, despite the decreased keratinocyte proliferation noted in experimental wounds in 
the present study, no significant differences were observed in the measures of epithelial 
restoration between experimental and control wounds on the same days. This suggests that 
silver nanoparticles did not substantively affect keratinocyte migration. Indeed, the only 
significant difference in the epithelium was in the thicker epithelium in the center of 
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experimental wounds, which more closely resembled normal epithelium, on day 15 post-
wounding. The similarity of normal epidermis and new epithelium in wounds treated with 
silver nanoparticle containing dressings is noted in a number of studies investigating different 
types of wounds (Wright et al., 2002; Bhol and Schechter, 2004; Tian et al., 2007; Liu et al., 
2010).  Unfortunately, Burd et al (2007), who reported decreased rates of re-epithelialisation 
in Acticoat
TM
-treated acute, full thickness wounds in pigs, did not comment on the character 
of the epithelium. However, Liu et al (2010) and the current study both suggest that silver 
nanoparticles have a beneficial effect on healing of the epidermis in acute full thickness 
wounds. 
 
The mechanisms by which silver nanoparticles affect re-epithelialisation in vivo are not well 
described. To the author’s knowledge, no reports describe the effect of silver nanoparticles on 
keratinocyte migration in vivo or in vitro. Furthermore, only the current study and Liu et al 
(2010) report the effects of silver nanoparticles on keratinocyte proliferation in vivo, in any 
wound model. Increased expression of keratinocyte growth factor and epidermal growth 
factor and decreased expression of interleukin-1, TNF-α and transforming growth factor 
(TGF)-β, which affect keratinocyte proliferation and/ or migration (Sivamani et al., 2007; 
Werner et al., 2007), were associated with increased re-epithelialisation of silver 
nanoparticle-treated wounds in a porcine model of contact dermatitis (Nadworny et al., 
2010). However, the effect of silver nanoparticles on other cytokines and growth factors 
important in regulating re-epithelialisation is unknown. Furthermore, the mechanisms by 
which silver nanoparticles affect re-epithelialisation in acute wounds, such as those 
investigated in this study, have not yet been reported. In addition to the effect of silver 
nanoparticles on fibroblast- keratinocyte and keratinocyte- immune interactions, the effect of 
silver nanoparticles on melanocytes and keratinocyte-melanocyte interactions may be of 
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interest. Melanocytes are resident in the epidermis and are important in normal keratinocyte 
homeostasis (Nordlund, 2007; MacLeod and Havran, 2011). The scope of this study did not 
include the identification of melanocytes using co-localisation of melanocyte specific 
antibodies with the Ki-67 antibody. Therefore, it is not known if the decrease in proliferating 
cells in the epidermis seen in experimental wounds included a decrease in the proliferation of 
melanocytes in addition to the decrease in the proliferation of keratinocytes. It would be 
worthwhile to investigate in future studies if keratinocyte-melanocyte interactions are in part 
responsible for the beneficial effects of silver nanoparticles on epithelial restoration.  
 
Silver nanoparticles may also have a beneficial effect on angiogenesis. While fewer blood 
vessels were noted in experimental wounds on day 15 post-wounding in the current study, a 
greater number of these blood vessels were more mature. Wright et al (2002) and Prestes et 
al (2012) also noted increased angiogenesis in Acticoat
TM
-treated wounds. Similarly, Kang et 
al (2011) observed functional blood vessels in silver nanoparticle-impregnated matrigel plug 
assays in mice. These observations suggest that the effects of silver nanoparticles on 
angiogenesis in vivo are not limited to decreasing endothelial cell viability. However, the 
mechanisms by which silver nanoparticles affect angiogenesis are also unknown. Complex 
interactions of different VEGF isoforms, angiopoeitins, platelet derived growth factor, TGF-β 
and other angiogenic factors occur during angiogenesis (Carmeliet and Jain, 2011). Thus, it is 
difficult to predict the effect of increased VEGF expression (Tian et al., 2007) and decreased 
TGF-B expression (Tian et al., 2007; Nadworny et al., 2010) caused by silver nanoparticles.  
However, as vessel maturation may affect scar formation (DiPietro, 2013), the observation 
that silver nanoparticles improve vessel maturation warrants further investigation.  
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In the present study, the effect of silver nanoparticles on scarring could not be assessed as too 
few wounds were re-epithelialised by day 15 post-wounding. In addition, attempts to quantify 
collagen deposition using the dye binding method described by Lopez-De Leon and Rojkind 
(1985) were unsuccessful. The large standard deviations observed in the concentrations of 
total protein and hydroxyproline suggest that the difficulty lies in the homogenization of the 
normal pig skin for these assays. However, significant differences were noted between 
experimental and control wounds in the scores for collagen organisation and bundle size. In 
addition, the values of all of the parameters assessing collagen decreased in experimental 
wounds from day 9 to 15 post-wounding. This suggests that silver nanoparticles affect 
collagen deposition in acute wounds in vivo.  
 
The hypothesis that silver nanoparticles influence collagen deposition in acute wounds is 
supported by Kwan et al (2011).  Murine full-thickness excisional wounds treated with silver 
nanoparticles (5-15nm, 0.04mg/cm
2
) contained more collagen which was better organized 
and aligned than in control wounds (Kwan et al., 2011). Furthermore, the tensile strength and 
mechanical properties of silver nanoparticle-treated wounds were significantly better than 
control wounds and not different from normal skin (Kwan et al., 2011). Similarly, increased 
collagen deposition was noted in mouse incisional wounds treated with chondroitin- and 
acharan-sulfate silver nanoparticles compared to Vaseline treated controls (Im et al., 2013). 
However, fibrosis was similar in Acticoat
TM
-treated wounds and wounds treated with distilled 
water in a rat model of excisional wounds (Prestes et al., 2012).  
 
In vitro studies (Arora et al., 2008; Hsin et al., 2008; AshaRani et al., 2009; Wei et al., 2010; 
Park et al., 2011; Rigo et al., 2013) and an in vivo investigation of full-thickness wounds in a 
mouse model (Liu et al., 2010) demonstrate that silver nanoparticles are toxic to fibroblasts. 
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Thus, decreased fibroblast viability is one mechanism through which silver nanoparticles may 
affect collagen deposition.  In the present study, Ki-67 immunolabelled sections were not 
suitable to evaluate the proliferation of fibroblasts due to the extent of disruption of the 
dermis by the antigen retrieval process. Therefore, it is unknown if differences in fibroblast 
proliferation are responsible for the differences in collagen deposition between experimental 
and control wounds.  
 
Silver nanoparticles may also influence ECM remodelling by increasing the number of 
myofibroblasts (Liu et al., 2010; Kwan et al., 2011) or by affecting the function of matrix 
metalloproteinases (Wright et al., 2002; Nadworny et al., 2008; Nadworny et al., 2010). 
However, studies which report decreased MMP function in silver nanoparticle-treated 
wounds do not comment on the formation of collagen, granulation tissue or scars (Wright et 
al., 2002; Nadworny et al., 2008; Nadworny et al., 2010). While Tian et al (2007) noted 
improved scarring in mouse burn wounds, clinical studies which describe the quality of scars 
note increased scarring in silver nanoparticle-treated wounds (Innes et al., 2001; Argirova et 
al., 2007). 
 
The findings of this study suggest that Acticoat
TM
 has beneficial effects on epithelial 
restoration, angiogenesis and collagen deposition in acute excisional wounds. These 
processes are important in accelerating healing and minimising scar formation (Reinke and 
Sorg, 2012; DiPietro, 2013). As healing of porcine skin is similar to human skin (Sullivan et 
al., 2001), these results are applicable to the clinical situation. Thus, scar prevention in acute 
wounds may be a novel indication for the use of Acticoat
TM
, in addition to the current uses of 
treating infection and decreasing inflammation in chronic wounds or deep partial thickness 
burns (Gravante and Montone, 2010; Widgerow, 2010).  
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However, further investigation is needed into the mechanisms by which silver nanoparticles 
affect healing in different types of wounds. In particular, the role of silver nanoparticles in 
inducing chronic inflammation in acute wounds should be examined more closely. Of interest 
may be the effect of silver nanoparticles on resident immune cells in the skin, including 
Langerhans cells and dendritic epidermal T cells, which modulate the immune response and 
keratinocyte and melanocyte function during normal homeostasis as well as healing 
(Nordlund, 2007; MacLeod and Havran, 2011).  In addition to the importance of 
keratinocyte-melanocyte interactions in normal homeostasis (Nordlund, 2007), a recent report 
has highlighted the potential role of melanocytes in stimulating the fibroblastic response 
leading to pathological scarring (Gao et al., 2013). Thus, in vitro and in vivo studies 
investigating the effect of silver nanoparticles on the migration, proliferation and 
differentiation of melanocytes, keratinocytes and fibroblasts and the interactions of these cells 
would be valuable. The processes of myofibroblast and pericyte differentiation share 
similarities (Carmeliet and Jain, 2011; Greaves et al., 2013). Therefore, the ability of silver 
nanoparticles to stimulate myofibroblast differentiation (Liu et al., 2010) may be of particular 
interest, as this mechanism may also influence pericyte differentiation, and thereby 
angiogenesis (Carmeliet and Jain, 2011) and scarring (DiPietro, 2013).  
 
Furthermore, the role of silver nanoparticles in influencing the levels of growth factors, 
cytokines, TIMPs and MMPs within the wound in vivo should be scrutinized. As silver 
nanoparticles have a particular affinity for cysteine rich proteins such as metallothioneins 
(Lansdown, 2010), their effect on proteins such as cysteine-rich 61 (cyr61), which is 
important in collagen deposition (Lau, 2011), should be explored. Such research may 
elucidate novel mechanisms, apart from the direct influence on fibroblast function (Liu et al., 
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2010), by which silver nanoparticles modulate collagen deposition and may have implications 
in scar prevention.  
 
Moreover, large, randomized controlled trials are needed to ensure any beneficial effects of 
silver nanoparticles reported in animal and in vitro studies also occur in the clinical setting. 
Such clinical studies are of importance in clarifying the role of silver nanoparticles in the 
treatment of acute and chronic wounds as well as burns, particularly in light of the paucity of 
studies which compare silver dressings to other treatment modalities (Storm-Versloot et al., 
2010; Aziz et al., 2012; O’Meara et al., 2013; Wasiak et al., 2013; Vloemans et al., 2014). 
 
Thus, silver nanoparticles may have beneficial effects on the healing of acute wounds. 
However, well-designed, methodologically sound studies are needed to determine the 
mechanisms by which silver nanoparticles affect healing and their role in the treatment of 
different types of wounds.  
 
Limitations 
Due to difficulties in the protocol for immunolabelling for Ki-67, only one section per wound 
was assessed to determine the number of proliferating keratinocytes. Thus, these results 
should be interpreted with caution. However, the clear differences noted between 
experimental and control wounds suggest that this is an area worthy of discussion and further 
investigation.  
 
Furthermore, in the current study five experimental and five control wounds were analysed 
for each day post-wounding. This sample size may prevent significant differences between 
experimental and control wounds from being apparent. Therefore, observation was used to 
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assess and verify the quantitative data. In addition, the sample size did not allow analysis of 
the effect of the pig, weight of the pig or region in which the wound was placed as compared 
to the effect of the dressing group on the variables studied. As experimental and control 
wounds were matched on each day post-wounding, the effect of the pig, weight and region 
was limited in the comparison of experimental and control wounds on the respective day 
post-wounding. However, the sample size restricted the analysis of the effect of Acticoat
TM
 
on healing across the days post-wounding as effect of the pig, weight and region could not be 
analysed.  
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5. CONCLUSION  
This study has shown that acute full-thickness excisional wounds treated with Acticoat
TM
 
heal at a rate comparable to those dressed with a polyurethane film dressing. This is in spite 
of an increased inflammatory response and decreased keratinocyte proliferation on day 3 
post-wounding. In addition, there is evidence that Acticoat
TM
-treated wounds have more 
mature blood vessels, different collagen deposition and epithelium which more closely 
resembles normal epithelium compared to the wounds dressed with polyurethane film 
dressings.  
 
The potent antimicrobial action combined with the low risk of resistance makes silver 
nanoparticle dressings valuable in the treatment of infected wounds. However, the findings of 
this study suggest that silver nanoparticle dressings may also have a role in improving 
scarring. Considering the complex and potentially beneficial effects of silver nanoparticles on 
healing, further investigation is warranted into the effects and mechanisms of action of silver 
nanoparticles in different types of wounds. This will clarify the role of dressings such as 
Acticoat
TM
 in the management burns and chronic wounds and elucidate new uses of these 
dressings in other wound types.  
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7. APPENDICES 
A. Ethical clearance certificate from the Animal Ethics Screening Committee of the 
University of the Witwatersrand 
 
 
 
PLEASE NOTE: Carol Mann became Carol Hartmann in 2010.  
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REAGENTS AND BUFFERS USED FOR HISTOLOGY 
B1. 10% buffered (neutral) formalin  
100ml  40% formaldehyde 
900ml Distilled water 
4g sodium dihydrogen phosphate monoxide  
6,5g di-sodium hydrogen orthophosphate anhydrous  
 
B2. Mayer’s Haematoxylin and Eosin stain 
 Haematoxylin:  Haematoxylin 4g  
 Distilled water 1000ml 
 Sodium iodate 0,3g 
 Potassium Alum 50g 
 Citric acid 1,5g 
 Chloral hydrate 75g 
 
 Eosin:  1% Eosin 500ml 
 1% Phloxine 250ml 
 Distilled water 750ml 
  
1. Incubate sections in two changes of xylene, two changes of 100% alcohol and one 
change of 95% alcohol (5 minutes each).  
2. Wash in running tap water for 5 min. 
3. Stain in haematoxylin for 5 minutes. 
4. Wash in tap water until excess stain removed. 
5. Dip in 1% Acid alcohol. 
6. Wash in running tap water for 5 minutes.  
7. Counter stain in Eosin for 30 seconds to 1 minute. 
8. Wash briefly in running tap water. 
9. Pass sections through one change of 95% alcohol, two changes of 100% alcohol and 
two changes of xylene before mounting the coverslip with entellan.  
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C. Ethical clearance certificate from the Human Research Ethics Committee of the 
University of the Witwatersrand 
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REAGENTS AND BUFFERS FOR IMMUNOCYTOCHEMISTRY  
C1. Tris EDTA buffer pH 9.0:   
 1.21g Tris  
 0.37g ethylenediaminetetraacetic acid (EDTA) 
 1000ml distilled water 
 Adjust pH using 1M HCl 
 0.5ml Tween 20  
 
C2. Initial immunocytochemistry protocol 
 
1. Incubate sections in two changes of xylene (10 minutes) before passing through two 
changes of 100% alcohol and one change of 95% alcohol. 
2. Wash in running tap water for 5 minutes. 
3. Incubate sections in EDTA (pH 9.0) in a microwave (900W) for 10 minutes.  
4. Cool at room temperature for 10 minutes.  
5. Incubate sections with 3% Hydrogen peroxide for 15 minutes at room temperature. 
6. Wash in running tap water for 5 minutes. 
7. Wash twice in TBS 1% BSA (Appendix C5) containing 0.025% triton for 10 minutes:  
8. Incubate each section with 75µl of 10% Normal Goat Serum in TBS 1% BSA for 45 
minutes at room temperature.  
9. Incubate each section with 100 µl of primary antibody (polyclonal rabbit anti-Ki-67 
antibody) diluted 1:1000 in TBS 1% BSA overnight at 4
o
C in a humidified chamber. 
10. Wash twice in TBS 1% BSA for 10 minutes. 
11. Incubate each section with 100µl of secondary antibody (goat anti-rabbit antibody) 
diluted 1:300 in TBS 1% BSA for 30 minutes at room temperature.  
12. Wash twice in TBS 1% BSA for 10 minutes.  
13. Incubate each section with 100µl of solution, obtained by mixing reagents A and B 
(ABC kit) with TBS 1% BSA as per the manufacturer’s instructions, for 30 minutes at 
room temperature.  
14. Wash twice in TBS 1% BSA for 10 minutes. 
15. Incubate each section with 100µl diaminobenzidine (DAB) (Appendix C6) for 5 
minutes at room temperature.  
16. Wash in running tap water for 5 minutes.  
17. Pass sections through one change of 95% alcohol, two changes of 100% alcohol and 
two changes of xylene before mounting the coverslip with entellan. 
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C3. Citrate buffer pH 6.0 or pH 8.0:  
2.94g trisodium citrate  
1000ml distilled water 
Adjust pH using 1M HCl.  
 
C4. 5% Tris Urea buffer pH 9.5:  
 24.24g Tris 
 100g urea crystals 
 2000ml distilled water 
 Adjust pH using 1M HCl 
 
C5. Tris Buffered Saline pH 7.6:   
 17,54g sodium chloride  
  12,12g Tris base  
  2000ml distilled water 
  Adjust pH to 7.6 with 5M HCl.  
 
To make TBS 1% BSA: Add 1g bovine serum albumin (BSA) (Sigma-Aldrich, USA) to 
100ml TBS. 
 
C6. DAB 
0.001g diaminobenzidine 
2ml Tris buffered saline  
To this solution add 20µl of a solution composed of 1µl 30% hydrogen peroxide in 29µl iced, 
distilled water. Vortex and filter before use.   
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REAGENTS AND BUFFERS FOR PICROSIRIUS RED STAINING AND 
HYDROXYPROLINE AND TOTAL PROTEIN DETERMINATION  
 
D1. Picrosirius red stain  
 0.5g Sirius Red F3B  
 500ml Saturated aqueous solution of picric acid  
Let solution stand for 24 hours before use.  
 
1. Incubate sections in two changes of xylene, two changes of 100% alcohol and one 
change of 95% alcohol (5 minutes each). 
2. Wash in running tap water for 5 minutes.  
3. Stain in haematoxylin for 8 minutes. 
4. Wash in running tap water for 10 minutes. 
5. Stain in picrosirius red for one hour. 
6. Wash in two changes of acidified water (2 minutes per change).  
7.  Pass sections through one change of 95% alcohol, two changes of 100% alcohol and 
two changes of xylene before mounting the coverslip with entellan. 
 
 
D2. Chloramine T reagent: 
 0.32g Chloramine T  
 5.2ml distilled water 
 6.5ml N-propanol 
 13.3ml stock buffer (Appendix D5) 
 
D3. Erhlichs reagent solution: 
 3.73g Dimethylaminobenzaldehyde  
   15ml N-Propanol  
  6.5ml Perchloric acid   
  Distilled water to final volume 25ml 
 
D4. Assay buffer: 
 1 part stock buffer (Appendix D5) to 10 parts distilled water 
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D5. Stock buffer: 
 50g Citric acid monohydrate 
 12ml glacial acetic acid 
 120g Sodium acetate trihydrate 
 34g Sodium hydroxide 
 1000ml distilled water 
 Adjust to pH 6.5 using 1M HCl 
 
D6. Homogenising buffer:  
 50mM Tris HCl (pH 7.5) 
 5mM acetate  
 0.2mM EDTA 
 10% glycerol  
 1% Triton X-100 
Add 500μl of 0.5M Dithiothreitol (Sigma-Aldrich, USA) and 50μl of protease inhibitor 
cocktail for general use (Sigma-Aldrich, USA) to 10ml homogenizing buffer just before 
protein extraction. 
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D7. Mean absorbance of serial dilutions of 0.01% Fast Green at 540nm and 620nm 
 
% Fast Green  Mean A620 (n=12) Mean A540 (n=12) A540/A620 (%) 
0.01 9.99 (+1.86 x 10
-5
) 0.37 (+0.005) - 
0.005 2.21 (+0.072) 0.22 (+0.006) 9.76 
0.0025 1.20 (+0.055) 0.13(+0.005) 11.18 
0.00125 0.65 (+0.027) 0.09 (+0.003) 13.90 
0.000625 0.35 (+0.015) 0.07 (+0.003) 18.98 
0.000313 0.20 (+0.008) 0.05 (+0.001) 26.58 
0.000156 0.12 (+0.003) 0.05 (+0.001) 38.98 
7.81 x10
-5
 0.08 (+0.005) 0.05 (+0.001) 53.73 
3.91 x10
-5
 0.06 (+0.002) 0.04 (+0.001) 68.21 
1.95 x10
-5
 0.06 (+0.001) 0.04 (+0.002) 81.02 
A620: Absorbance at 620nm; A540: Absorbance at 540nm; A540/A620: Absorbance at 540nm 
expressed as a percentage of the absorbance at 620nm.  
Relationship defined by the equation: A540= 0.08(A620) + 0.039 (r=0.99) 
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D8. Calculation of the colour equivalences (CE) for total protein (TP) and collagen.  
Area of 
skin 
Collagen 
(mg/ml) 
TP (mg/ml) A620 Corrected 
A540   
Collagen 
CE 
TP CE 
Pig 1 
dorsum 
0.08 
+ 0.01 
0.87 
+ 0.11 
0.20 0.99 13.00 0.25 
Pig 2 
dorsum 
0.09 
+ 0.01 
0.65 
+ 0.26 
0.32 1.68 18.86 0.57 
Pig 3 
dorsum 
0.10 
+ 0.02 
0.67 
+ 0.17 
0.21 1.20 12.57 0.37 
Pig 4  
abdomen 
0.15 
+ 0.02 
0.67 
+ 0.10 
0.20 1.07 7.06 0.38 
Pig 4 
dorsum 
0.08 
+ 0.003 
0.87 
+ 0.50 
0.36 1.62 20.75 0.45 
Pig 5 
abdomen 
0.10 
+ 0.02 
0.95 
+ 0.25 
0.19 0.74 7.25 0.22 
Pig 5 
dorsum 
0.09 
+ 0.31 
0.75 
+ 0.17 
0.44 2.21 24.37 0.67 
Pig 6 
dorsum 
0.10 
+ 0.25 
0.70 
+ 0.09 
0.68 2.39 24.98 1.12 
Pig 7 
abdomen 
0.10 
+ 0.50 
0.83 
+ 0.14 
0.33 1.30 13.24 0.45 
Pig 7 
dorsum 
0.10 
+ 0.86 
0.59 
+ 0.29 
0.32 1.86 19.28 0.66 
A620: Absorbance at 620nm; Corrected A540: Absorbance at 540nm excluding contribution of 
Fast Green (Calculated using the equation in Appendix D7) 
Colour equivalences calculated using the following formulae (Lopez-De Leon and Rojkind, 
1985):   Colour equivalence of collagen =  Corrected A540   
      Mean collagen value 
Colour equivalence of total protein =  A620   _________________ 
          Mean total protein value- mean collagen value 
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REAGENTS AND BUFFERS FOR GRAM STAINING  
E. Gram method for paraffin sections (Bancroft and Gamble, 2002) 
 
Crystal Violet Solution 
 0.5% Crystal Violet in 25% alcohol. Filter before use. 
 
Lugol’s Iodine solution 
 Iodine 1.0g 
 Potassium iodide 2.0g 
 Distilled water 300ml 
 Dissolve the potassium iodide in 10ml distilled water.  
 Add the iodine and mix before adding the remaining distilled water.  
 
Neutral red 
 Neutral red 1.0g 
 Acetic acid 2ml 
 Distilled water 1000ml 
 Filter before use. 
 
1. Incubate sections in two changes of xylene, two changes of 100% alcohol and one 
change of 95% alcohol (5 minutes each). 
2. Wash in running tap water for 5 minutes and rinse in distilled water.  
3. Stain in crystal violet for 2 minutes. 
4. Wash in running tap water and drain off excess water. 
5. Stain in Lugol’s iodine for 2 minutes. 
6. Rinse in running tap water. 
7. Working with single sections, blot each section dry and differentiate by dipping in 
95% alcohol.  
8. Wash in running tap water. 
9. Stain in neutral red for 3 minutes. 
10. Blot and dehydrate rapidly by passing sections through one change of 95% alcohol, 
two changes of 100% alcohol and two changes of xylene before mounting the 
coverslip with entellan. 
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F. Lin’s concordance correlation and Cohen’s kappa coefficients  
 Intra-error (Left/ Right) Inter-error (Left/ Right) 
Percentage change 0.99 0.91 
Epithelial gap (µm) 0.99 0.98 
% by which the wound 
has closed 
0.99 0.95 
Area of the regenerated 
epithelium (µm
2
) 
1.00 0.91 
Epithelial tongue length 
(µm) 
1.00 0.97 
Epithelial thickness at the  
wound edge (µm) 
0.99/ 0.97 0.98/ 0.99 
Epithelial thickness at the 
tip of the epithelial tongue 
(µm)  
0.99/ 0.99 0.88/ 0.96 
Average score for hair 
follicles 
0.96/ 0.90 0.83/ 0.87 
Number of inflammatory 
cells 
1.00 0.98 
Average score for  
blood vessel type 
0.83/ 0.86 0.86/ 0.86 
Average score for  
blood vessel number 
0.85/ 0.85 0.86/ 0.81 
Number of proliferating 
keratinocytes 
0.99 0.99 
% area of collagen (µm
2
) 1.00 0.99 
Average score for collagen 
density 
0.95 0.95 
Average score for collagen  
bundle size 
0.98 0.95 
Average score for collagen 
organisation 
0.97 0.89 
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G. Results of the Shapiro-Wilks test by day post-wounding and treatment group 
 Day 3 Day 6 Day 9 Day 12 Day 15 
E C E C E C E C E C 
Percentage change 
in area over time 
0.001 0.27 0.70 0.03 0.99 0.51 0.28 0.03 0.88 0.04 
Size of the 
epithelial gap (µm) 
N N N N 0.09 0.50 N N - 0.0001 
Percentage by 
which the wound 
has closed 
N N N N 0.32 0.44 N N - 0.0001 
Width of the 
wound area (µm) 
N N N N 0.93 0.04 N N 0.12 0.14 
Area of the 
epithelial tongue 
(µm
2
) 
0.71 0.90 0.23 0.28 0.66 0.93 N N 0.34 0.67 
Length of the 
epithelial tongue 
(µm) 
0.30 0.43 0.38 0.91 0.13 0.48 N N 0.48 0.57 
Thickness of the 
epithelium at the  
wound edge (µm) 
0.23 0.16 0.99 0.92 0.72 0.82 N N 0.76 0.44 
Thickness of the 
epithelium at the 
tip of the epithelial 
tongue (µm) 
0.64 0.40 0.28 0.53 0.75 0.95 N N 0.16 0.07 
Score for 
epidermal 
appendages 
0.02 0.02 0.42 0.31 0.45 0.05 N N 0.15 0.20 
Number of 
proliferating 
keratinocytes 
0.76 0.03 0.28 0.03 0.43 0.47 N N 0.83 0.91 
Number of 
inflammatory cells 
0.89 0.31 0.02 0.16 0.49 0.44 N N 0.84 0.10 
Score for  
blood vessel type 
- - - 0.05 0.27 0.38 N N 0.01 0.15 
Score for  
blood vessel 
number 
- - 0.31 0.68 0.0001 0.66 N N 0.01 0.42 
Percentage area of 
collagen (µm
2
) 
0.85 0.16 0.49 0.76 0.39 0.87 N N 0.94 0.71 
Score for collagen 
density 
- - 0.65 0.86 0.70 0.07 N N 0.95 0.42 
Score for collagen  
bundle size 
- - 0.46 0.69 0.03 0.97 N N 0.0001 0.49 
Score for collagen 
organisation 
- - 0.74 0.95 0.35 0.78 N N 0.35 0.42 
E: experimental wound, C: control wound; N: parameter not measured on that day post-wounding.  
Please note: - indicates parameters which could not be tested as all results equaled a single value, bold values 
indicate data that are not normally distributed (p<0.05) 
